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ABSTRACT 
Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental disorder with 
hallmark symptoms that can be severely impairing to both the individual and the overall family 
dynamic. The path to diagnostic and therapy services is often lengthy and complex. Despite 
various state and federal efforts to improve service access, disparities remain evident across 
ethnic, socioeconomic, and geographic lines with caregivers reporting financial, cultural, 
geographic, and practical (e.g., transportation, scheduling) barriers. For those able to access 
treatment, several interventions have been proven efficacious in addressing ASD symptoms, 
problem behaviors, and adaptive skills deficits. Other often-used interventions include those 
without established merit for ASD. This study found a tendency for income, insurance type, and 
ethnicity to affect service access. Out of pocket costs remain a significant barrier to evidence-
based services. Scheduling difficulties and long wait lists impact diagnostic services, as do 
perceptions of misguided reassurances from professionals (e.g., healthcare worker stating “he’ll 
grow out of it”). Disparities in service use indicate a need to develop policy, practice, and 
family-level strategies to address barriers to ASD services.  
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CHAPTER 1: INTRODUCTION 
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder marked by 
difficulties in three domains: communication, socialization, and restricted or repetitive behaviors, 
activities, or interests (e.g., hand flapping, preoccupation with parts of objects, intense interest in 
narrow subjects; Matson, Dempsey, & Fodstad, 2009). As a neurodevelopmental disorder, ASD 
is present from birth, is typically evident in early childhood, and is usually diagnosed in the first 
few years of life.  Until the recent publication of the 5
th
 edition of the Diagnostic and Statistical 
Manual of Mental Disorders in May 2013 (DSM-5; American Psychiatric Association [APA], 
2013), ASD as a DSM-IV-TR category included five disorders.  As outlined in the previous 
version of this widely used manual, the DSM-IV-TR (APA, 2000), these disorders included 
Autistic Disorder, Asperger’s Disorder, Rett’s Disorder, Childhood Disintegrative Disorder, and 
Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS); each disorder was 
marked by varying degrees of deficiencies in communication, social skills, and repetitive / 
restricted behaviors or interests.  
Significant changes in ASD diagnostic criteria in the DSM-5 (APA, 2013) include 
removal of Rett's Disorder and the collapse of the remaining diagnoses into one diagnosis: 
Autism Spectrum Disorder.  Socialization and communication deficits have been combined into 
one domain in which an individual must meet all three symptoms (i.e., deficits in nonverbal 
communication during social interactions, lack of social reciprocity, and deficits in developing 
and maintaining developmentally appropriate relationships) in order to receive an ASD diagnosis 
(APA, 2013).  Under the DSM-5, individuals must also meet two of the following criteria: 
stereotyped or repetitive speech, motor movements, or object use; adherence to routines or 
ritualized patterns of behavior; highly restricted interests which are abnormal in intensity or 
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focus; or abnormal hypo- or hyper-reactivity to sensory input.  The age of onset criterion 
includes early childhood, noting that some symptoms may not be fully evident until social 
demands exceed the individual’s level of functioning.  To fully meet criteria for an ASD 
diagnosis, symptoms must negatively impact the individual’s ability to function in activities of 
daily living.  Lastly, individuals carrying an ASD diagnosis that was diagnosed using the DSM-
IV-TR are permitted to retain their ASD diagnosis as the DSM-5 is adopted.  In the future, 
however, these changes will undoubtedly impact the prevalence of ASD. 
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CHAPTER 2: PREVALENCE AND DIAGNOSTIC DISPARITIES  
 Prevalence of Autism Spectrum Disorder 
In the early years of diagnostic conceptualization, ASD was considered to be a very rare 
disorder. Mid-20
th
 century prevalence estimates indicated fewer than 10 in 10,000 individuals 
met ASD criteria at that time (Sevin, Knight, & Braud, 2007). Prevalence rates have increased 
drastically from these early estimates, reaching approximately 30-60 per 10,000 in the early 
1990s (Inglese & Elder, 2009). Prevalence estimates released by the Centers for Disease Control 
and Prevention (CDC) indicated a prevalence of 1 in 150 in 2007 (CDC, 2007). More recent 
estimates increased to 1 in 88 (CDC, 2012) and then 1 in 68 (CDC, 2014), with a corresponding 
rise in concern about an autism “epidemic.” Throughout the years, the male to female ratio 
described by Leo Kanner in the 1940s of approximately 4:1 has remained stable (Bertoglio & 
Hendren, 2009; Dawson, Mottron, & Gernsbacher, 2008; Rice et al., 2010; Inglese & Elder, 
2009). In a recent epidemiological study, researchers estimated that there is little regional 
variation worldwide in ASD prevalence, with an average rate of approximately 1 in 132 (Baxter 
et al., 2014). 
 While ASD diagnostic rates have undoubtedly increased over the years, it is impossible 
to pinpoint a specific reason for the increase. It is likely that a confluence of factors have 
contributed to increased diagnostic rates. Differing methodology in various estimates affects 
results (Fombonne, 2009, Matson & Kozlowski, 2011). Furthermore, prevalence rates have been 
affected by changes to the criteria between DSM editions (Fombonne, Quirke, & Hagan, 2009; 
Matson & Kozlowski, 2011; Shattuck, 2006). Changes to criteria over the years may lead to 
diagnostic substitution; even minor changes in criteria may shift individuals from meeting 
criteria in one diagnostic category to another, and thus effect change in apparent prevalence rates 
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(Fombonne, 2009; Matson & Shoemaker, 2009). For example, changes between DSM editions 
have led to concomitant increases in ASD rates and decreases in intellectual disability (ID) rates 
in a process called diagnostic substitution (Fombonne, 2009; Leonard et al., 2010), though now it 
is customary to give both diagnoses where warranted with ASD as a primary diagnosis and ID as 
a secondary diagnosis (Matson & Shoemaker, 2009). ASD criteria were most recently updated 
with the release of the DSM-5 in 2014; it is as yet unclear how much this change will affect 
prevalence rates. Though only time will tell, some researchers anticipate 30% or more decrease 
in new diagnoses due to the introduction of more stringent criteria that would likely exclude 
many who met DSM-IV-TR criteria for PDD-NOS, Asperger’s Disorder, or ASD without 
concurrent ID (Frazier et al., 2012; Matson, Belva, et al., 2012; Mattila et al., 2011; McPartland 
et al., 2012; Worley & Matson, 2012).  
Other factors impacting prevalence rate include increased awareness and acceptance of 
ASD, increased awareness of early symptoms, and increased service availability and screening 
efforts (Fombonne, 2009; Koenig et al., 2000; Leonard et al., 2010; Matson & Kozlowski, 2011). 
Increased awareness of ASD can lead to better identification, treatment, and outcome for many 
affected individuals, but increased awareness also increases the chance for misdiagnosis.  ASD 
diagnosis can be complicated by heterogeneity of symptom expression and symptom overlap 
with other conditions (e.g., communication disorders; Matson & Kozlowski, 2011); it is likely 
that inexperienced clinicians may occasionally misdiagnose ASD, and it is possible that ASD 
diagnosis is being over-used (Leonard et al., 2010; Matson & Kozlowski, 2011). Additionally, it 
is possible that shifting environmental factors contribute to increased actual cases of ASD. 
Etiology is yet undetermined, but research indicates a confluence of biological and 
environmental factors increase the risk for ASD symptoms (Inglese & Elder, 2009).  Fortunately, 
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the survival rate for premature births has increased significantly over the years; however, 
prematurity is recognized as a risk factor for later ASD diagnosis (Matson & Kozlowski, 2011). 
Improved medical care likely contributes to increased survival of children with risk factors (e.g., 
prematurity, genetic conditions) who go on to receive an ASD diagnosis.  
Other factors affecting prevalence estimates include geography and cultural factors. 
Particularly in Asian countries, the concept of ASD is a relatively new one (Leonard et al., 2010; 
Matson & Kozlowski, 2011). In the United States, recent estimates have found significant 
differences in prevalence across ethnic groups; for example, the 2007 estimates released by the 
CDC noted significantly higher rates of ASD in non-Latino white children compared to minority 
groups (CDC, 2007). Perhaps affected by increased awareness and culturally sensitive diagnostic 
efforts, a decrease in the ethic gap was noted in the 2012 CDC report, though differences still 
exist (CDC, 2012), as discussed in the section on Diagnostic Process.  
Diagnosis and Diagnostic Disparities 
ASD is a neurodevelopmental disorder, so it is unsurprising that symptoms often become 
evident early on in life.  Currently, researchers indicate that ASDs can often be reliably 
diagnosed as early as 18 months of age, with some researchers positing that the appropriate 
screening tools and assessment practices can reliably diagnose some children as young as 12 
months of age (Council on Children with Disabilities, 2006; Kim & Lord, 2012). Parents often 
report concerns about their child’s development before one year of age, long before other 
caregivers or healthcare providers notice concerning signs (Kishore & Bashu, 2011). Jónsdóttir 
and colleagues (2011) found that of children who later received an ASD diagnosis, 76.2% of 
parents were concerned about their child’s development before 3 years of age (Jónsdóttir, 
Saemundsen, Antonsdóttir, Sigurdardóttir, & Ólason, 2011).  
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Despite parents’ early concerns, many children are not diagnosed with ASD until school 
age. Shattuck and colleagues (2009) reviewed educational and medical records from 13 sites 
across the United States, and found that the median age at ASD diagnosis was 5.7 years. In this 
same study, the researchers noted that 27% of the students had undiagnosed ASD at age 8 years.  
Under the DSM-IV-TR criteria, which divided ASDs into Autistic Disorder, PDD-NOS, and 
Asperger’s Syndrome, the CDC (2012) found the average age of diagnosis ranged from 4 years 
(Autistic Disorder) to 6 years, 3 months (Asperger’s Disorder). In the case of children with 
Autistic Disorder, the most severe ASD category in the DSM-IV-TR, Chakrabarti (2009) found 
parents became concerned about their child’s development when the child was around 23.4 
months of age, and sought professional help approximately 4 months later. Despite an average 
point of first professional contact around 27 months, the mean time from the first evaluation to 
the diagnosis was 32 months (Chakrabarti, 2009). In total, this indicates a gap of about 2.5 years 
from point of first concern to a formal ASD diagnosis for the most severely affected category of 
children in this study—time during which the child and family might have benefitted from early 
intervention services.  Interestingly, maternal age over 35 years has been associated with later 
recognition of autism symptoms by parents (Chawarska et al., 2006). 
Many children receive one or more other psychological and/or developmental diagnoses 
before finally receiving an ASD diagnosis. To investigate the possibility of misdiagnosis, 
Yeargin-Allsopp and colleagues (2003) conducted a thorough review of educational and/or 
medical records to ascertain whether an ASD diagnosis was present in prior records and found 
18% of children enrolled in special education services at that time had not been correctly 
classified as having an ASD. It can take months to receive an accurate ASD diagnosis even when 
developmental concerns are noted early on.  Symptoms are heterogeneous, and may emerge or 
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change over time, highlighting the necessity of periodic re-evaluation. Individual factors 
associated with later diagnosis include being female, IQ over 70, moderate to mild ASD 
symptoms, and absence of developmental regression (Shattuck et al., 2009).  
Recent efforts to improve early diagnosis have increased general awareness of early 
symptoms among parents and health care professionals, and resulted in greater research and 
development of measures designed for early ASD screening. These efforts have contributed to 
decreases in the average age of diagnosis (Charman & Baird, 2002). However, evident disparities 
in the diagnostic process still exist. Race, ethnicity, socioeconomic status (SES), and rural versus 
urban location remain concerns for professionals seeking to improve diagnostic and treatment 
services. 
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CHAPTER 3: INTERVENTIONS 
 According to the American Psychological Association, evidence-based practice (EBP) is 
practice that applies empirically supported principles to integrate the best available research with 
clinical expertise in the provision of psychological interventions (APA, 2002). The APA 
encourages EBP to “promote effective psychological practice and enhance public health,” while 
acknowledging that an intervention that has not yet been carefully studied may one day prove to 
be effective (APA, 2002). Establishing treatments as EBP requires multiple carefully conducted 
research trials, and it takes time to gather enough strong evidence for any new efficacious 
intervention to become widely recognized as EBP. The need for establishing guidelines to 
separate EBP and non-EBP is based in the potential dangers of providers delivering non-EBP. 
Some non-EBPs may eventually be proven efficacious after adequate research, but wide use of 
non-EBPs exposes treatment-seeking individuals to greater risk of wasting time and resources on 
ineffective interventions, instead of allocating resources towards those interventions more likely 
to be efficacious. Greater ill effects of pursuing non-EBPs are also possible. In the treatment of 
ASD, non-EBPs range from relatively benign (e.g., animal-assisted therapy) to downright 
dangerous (e.g., chelation therapy), including controversial treatments (shock therapy) and 
interventions that have been proven effective for other conditions but not for ASD (e.g., gluten-
free diet for individuals with celiac disease; National Autism Center, 2015).  Navigating the 
ocean of touted autism interventions can be daunting with information regarding both EBP and 
non-EBP readily available via social media, support groups, etc. Information on EBP and non-
EBP can even be found in the grocery checkout aisle (at least in Austin, Texas), where in 2012 
the author picked up issues of Autism Science Digest (issues 3 and 4) and Autism File: Hope and 
Help for Autism Families (issue 44). These magazines had headlines such as “Fermentation and 
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the Gut: The Suppression of Science,” “Stem Cell Therapy, Quantitative EEG, & Fecal 
Microbiota Transplantation,” “Breakthrough Vision Therapy: Transforming Learning and 
Behavior” and “Therapeutic Application of Transcranial Magnetic Stimulation in Autism 
Spectrum Disorders.” When one can so easily pick up scientific-sounding journals with articles 
written by MDs including statements such as “Hyperbaric therapy has been shown to be 
beneficial in the treatment of autism. . . it is possibly that hyperbaric therapy may be acting 
through mitochondrial hormesis to decrease oxidative stress and improve underlying metabolic 
abnormalities in autism” (van Dyke, 2012) it is no wonder that parents may have difficulty 
sorting out the wheat from the chaff when making treatment choices. (It appears that the Autism 
Science Digest is now defunct, although its parent organization, Autism One, still hosts popular 
annual conferences for parents with topics similar to those found in the former Digest.)  
The National Autism Center initiated the National Standards Project to provide 
guidelines informing professionals, educators, and caregivers about which treatments have been 
shown effective in treating individuals with ASD (National Autism Center, 2015).  The National 
Standards Project categorizes a number of ASD interventions as established interventions, 
emerging interventions (supported by some preliminary research results, but studies are not of 
number and/or rigor to qualify them as EBP), and unsubstantiated.  
 Deyro and colleagues (2014) surveyed parents of children with ASD regarding available 
ASD treatments and their perceived effectiveness and scientific validity of treatments included in 
the National Standards Project. These researchers found that the majority of parents agreed with 
the National Standards Report for only 9 out of the 26 treatments included in their survey. The 
authors concluded much work remains for professionals who regularly interact with parents of 
children with ASD in educating them and guiding them towards treatments most likely to be 
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efficacious. Complicating this goal, some non-EBPs are frequently recommended by clinicians 
and advertised on the internet in places likely to be frequented by parents (Deyro, Simon, & 
Guay, 2014).  
Established Interventions for Autism Spectrum Disorder 
Methods Using Principles of Applied Behavior Analysis (ABA) 
According to the National Standards Project, the principal category of established ASD 
interventions is Behavioral Interventions. This category includes a number of behavioral 
intervention packages that incorporate antecedent interventions (to modify the situational events 
typically preceding a target behavior) and consequent interventions (making changes to the 
environment following an instance of the target behavior; NAC, 2015). The identification of 
antecedent and consequent interventions is generally based on Applied Behavior Analysis 
(ABA), a process of systematically applying behavioral principles of human behavior and 
learning to effect desirable change in social behaviors (e.g., decreasing problem behaviors, 
teaching functional social skills and alternate behaviors, and increasing desirable behaviors in the 
appropriate situational context). In the course of the National Standards Project, 298 research 
articles on behavioral interventions were reviewed in the first phase and 155 articles in the 
second phase, providing an ample research base supporting the efficacy of behavioral 
interventions.  
 Complicating the description of these most effective behavioral treatments, many 
intervention packages share ABA-based application techniques. Common elements include 
prompting, shaping, use of natural consequences, naturalistic teaching strategies, contingent 
reinforcement, differential reinforcement, extinction, chaining, function-based intervention, 
reinforcement schedules, response interruption and redirection, joint attention intervention, 
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stimulus fading, modeling (video and/or live), repeated practice, discrete trial training, and other 
techniques. An in-depth description of these ABA-based elements is beyond the scope of this 
paper, but the interested reader may consult Matson (2009) and Fisher and Piazza (2013) for 
greater detail of these and other individual components. Early Intensive Behavioral Intervention 
(EIBI) is a behaviorally-based intervention; however, as EIBI is often studied as a separate 
treatment package, and is limited to the first years in life (early childhood), it will be discussed in 
more depth below. 
Early Intensive Behavioral Intervention (EIBI) 
Early intensive behavioral intervention (EIBI) is a treatment based on the principles of 
applied behavior analysis. EIBI is also sometimes referred to as Comprehensive Behavioral 
Treatment for Young Children (CBTYC; NAC, 2015). This intervention is usually delivered for 
2-3 years starting in early childhood at an intensity of 20 to 40 hours per week. Typical 
interventions include discrete trial teaching, incidental teaching, behavioral momentum, shaping, 
modeling, errorless learning, and other ABA-based techniques. Instruction may be carried out in 
multiple settings such as home, community, inclusive classrooms, self-contained classrooms, and 
small group instruction (NAC, 2015). Each program is highly individualized but nonetheless 
includes a strong application of ABA-based strategies. The National Standards Project reports of 
EIBI/CBTYC were based on the review of 21 and 20 studies respectively in phases 1 and 2 of 
the project. EIBI is one of the most well-studied and research-supported interventions for 
improving prognosis for young children diagnosed with ASD (for review, see Reichow, Barton, 
Boyd, & Hume, 2012; and Tonge, Bull, Brereton, & Wilson, 2014).  
Within the context of the family, early intervention services for children with ASD can 
support positive outcomes not only for the individual, but also for the family unit.  On an 
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individual level, early intervention can improve social skills, communication skills, challenging 
behaviors, family functioning, and perhaps even IQ  (American Academy of Pediatrics 
Committee on Children with Disabilities, 2001; Committee on Educational Interventions for 
Children with Autism, 2001; Manning-Courtney et al., 2003; Martinez-Pedraza & Cater, 2009; 
Matson, 2007; OCDD, 2012; Symes, Remington, & Brown, 2006), reducing the impact of delays 
and potentially decreasing the intensity needed for future supports. Ben-Itzchak and Zachor 
(2007) conducted a review of early behaviorally-based intervention studies, and found that 
approximately half of participants later exhibited significant improvement in standardized testing 
scores, peer to peer interactions, and functioning in mainstream classes.  On a family level, early 
intervention services may reduce the future costs to meet special education, rehabilitation and 
health care needs; reduce feelings of isolation, stress, and frustration by family members and 
caregivers; and help children become more productive and financially and socially independent 
of primary caregivers in the future (Matson, 2007; OCDD, 2012).   
Clinicians and researchers generally agree that an earlier diagnosis and subsequent 
treatment based on the principles of applied behavior analysis improves overall prognosis 
(Matson, Wilkins, & Gonzalez, 2008), in addition to improving family functioning. 
Acknowledging the importance of early intervention services in promoting positive outcomes, in 
1986 the United States Congress established Part C (Early Intervention) of the Individuals with 
Disabilities Education ACD (IDEA). Legislators recognized the “urgent and substantial need” to 
improve the development of infants and toddlers with disabilities, reduce educational costs by 
diminishing the later need for special education, curtail the likelihood of institutionalization 
while increasing independence, and support the ability of families to meet their child's needs 
(Data Accountability Center, 2012). Recognition of the value of early intervention has increased 
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focus on early detection (Gutierrez et al., 2009; Hayward, Gale, & Eikeseth, 2009), and programs 
to make early intervention services accessible irrespective of SES.  
Cognitive Behavioral Intervention Package (CBIP) 
 Between publication of National Standards Project phase 1 and phase 2 results, the 
cognitive behavioral intervention package was moved from the “emerging interventions” 
category and recategorized as an established intervention (NAC, 2015). Cognitive behavioral 
therapy (CBT) has been used as an evidence-based intervention for many years in the treatment 
of anxiety and mood disorders in individuals without ASD. Per National Standards Project 
review of 13 research studies investigating the use of CBT in individuals with ASD, manualized 
CBT with a few modifications can be an effective intervention for individuals with ASD. 
Modifications may include the addition of visual cues, use of role-play, and other elements of 
individualized structure added to the session. Common CBIP strategies include psychoeducation 
around identifying and describing emotions and corresponding physiological components. 
Cognitive restructuring can be used in a manner very similar to the way in which it is used for 
individuals without ASD to assist in recognizing and modifying cognitive distortions such as all-
or-nothing thinking or catastrophizing. Like other manualized CBT interventions for individuals 
without ASD, use of CBT in the course of ASD includes use of a scale to identify the magnitude 
of various distressing situations, homework assignments to record behavioral observations and 
work on identified skills at home and school/community, and parent sessions or inclusion of 
parents in parts of the intervention sessions (NAC, 2015).  Manuals reviewed by the NAC (2015) 
for use in individuals with ASD include the Coping Cat Program and the Exploring Feelings 
program.  
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Language Production Training  
 Language production training is often, but not always, given in the form of speech 
therapy sessions. Language production training targets the use of functional, spoken (verbalized) 
language communication.  Intervention begins with assessment and identification of 
developmentally appropriate targets, followed by use of a variety of strategies to elicit functional 
verbalizations. Strategies include modeling, prompting (e.g., verbal, visual, or gesture), cue-
pause-point procedure, incorporation of music, and reinforcement for production of the targeted 
verbal response (NAC, 2015).  
Parent Training Package 
 In the first phase of the National Standards Project, elements of the parent training 
package were reviewed individually; however, in the second phase, elements of parent training 
which generally occur in tandem were investigated as a whole. Effective parent training can 
occur in a variety of forms including in vivo, group training, support groups with an educational 
component, and training manuals. Skills commonly taught to the parents include strategies to 
cultivate imitation skills, commenting on the child’s behavior, expectant waiting to elicit 
communication, increasing joint attention, developing play date activities, and fostering suitable 
sleeping routines (NAC, 2105). 
Peer Training Package 
Many individuals with ASD desire and attempt to interact with peers, but do so in 
counterproductive ways. Similar to the parent training, in peer training skills are taught to those 
who regularly interact with the individual in order to help foster the individual’s social and other 
adaptive skills. One goal of peer training is to decrease an individual’s reliance on adults for 
prompting and guiding, and to instead train peers how to initiate and respond to social 
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interactions with an individual with ASD. These programs are used primarily in school and 
community settings, and have been found effective in increasing communication and 
interpersonal skills as well as decreasing restricted, repetitive behaviors, interests, or activities in 
shared social settings.  Important factors for consideration include the maturity and skill level of 
the child with ASD as well his/her peers, activities that incorporate interests of all parties 
involved to increase motivation, and teaching of specific skills for peers to get attention of the 
individuals with ASD in order to model appropriate play skills, facilitate sharing, provide help, 
and organize play activities (NAC, 2015). Interaction should occur in a structured setting around 
familiar activities with the instructor available to provide prompts and feedback. Training should 
occur in multiple settings and with a variety of peers. Some of the effective peer training 
curriculums/strategies in the National Standards Project include Project LEAP, circle of friends, 
buddy skills packages, facilitated integrated play groups, peer initiation training, and peer-
mediated social interaction training. 
Pivotal Response Training (PRT) 
 Like other EBPs discussed above, PRT makes use of ABA-based techniques. Unlike 
some of the previously discussed treatments, PRT is a package carrying a registered trademark; it 
was registered by Koegel and Koegel, researchers from Santa Barbara, California. PRT focuses 
on naturalistic teaching strategies. Rather than focusing on specific target behaviors, PRT targets 
motivation, responsiveness to cues, self-management, empathy, and self-initiated activities. 
Child choice, natural and direct reinforcers, and interspersing maintenance tasks, and variation of 
tasks are used to maintain motivation. Of note, these strategies are not unique to PRT and are 
often incorporated in other ABA-based approaches as well. Delivery of PRT relies on parent 
involvement and implementation in the natural environment such as home, community, and 
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school setting. National Standards Project’s review of PRT yielded a total of 16 research studies 
focusing on PRT; reviewers concluded these studies were of sufficient rigor to qualify the PRT 
package as an established intervention for ASD (NAC, 2015).  
Schedules 
Individuals with ASD often respond better to visual than to auditory cues, and many have 
difficulty with transitions. Individuals with ASD are able to better navigate transitions when they 
know what is coming next. Schedules make use of visual information (via picture or text) to help 
the individual know what is coming next, understand first/then concepts, and incorporate choice 
into the daily schedule of required activities. Use of schedules varies widely depending on the 
individuals’ abilities and needs. Schedules may be as simple as placing the corresponding 
picture/text in a designated place to signal the beginning and/or end of an activity, pointing to 
provide cues for what comes next, removing the cue when the task is completed, or placing the 
picture in a “done” pile (NAC, 2015). Schedules are often incorporated into other interventions.  
Scripting 
Scripting involves developing a scenario (often written) to assist an individual in verbally 
responding to certain social situations. Scripts target specific skills or situations (e.g., asking for 
help or for a break) that is practiced repeatedly before the skill is used in an in vivo, real-life 
situation. These methods are generally used in tandem with other behavioral interventions. In 
order to use scripting, the individual must have prerequisite reading and/or imitation skills.  The 
end goal is to eventually fade scripting and increase the variety and spontaneity of responses 
(NAC, 2015).  
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Self-Management 
The goal of self-management is to increase independence in a given situation, particularly 
in tasks where adult supervision is not usually needed or expected. Self-management involves 
teaching the individual to be aware of, evaluate, and record their own performance while 
engaging in an activity, and can be used to help monitor social and disruptive behaviors. The 
process should include concrete criteria defining success, systematic methods for recording 
performance (e.g., counters, checklists), adults who can provide feedback regarding accuracy of 
recording and provide prompts during learning stages, and teaching the ability to independently 
access reinforcers after meeting pre-established criteria. Self-management has primarily been 
studied in adolescents and young adults (NAC, 2015).  
Social Skills Package 
Social skills encompass a large number of skills such as eye contact, joint attention, use 
of nonverbal communication/gestures, reciprocal conversation or engagement in a social 
exchange, and both initiating and ending an interaction. A number of similar social skills 
packages exist; the goal of each is to increase the ability of an individual to participate in various 
social settings by teaching necessary social skills. Packages typically include elements of 
modeling, reinforcement and prompting, regardless of if sessions are one-on-one, in a peer dyad, 
small group, or other social situation (NAC, 2015).  
Story-Based Interventions  
Story-based interventions target a specific behavior by using a written description of the 
situations in which a specific response is expected. For example, stories may target perspective-
taking skills to teach an individual not to laugh when a peer gets injured or is crying. 
Individualized stories are typically written from an “I” or “some people” point of view. Stories 
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identify target behavior, situations in which behavior is expected, and likely outcome of 
engaging in the target behavior (which often includes information about others’ expected 
interpretations or reactions; NAC, 2015).  
Emerging Interventions for Autism Spectrum Disorder 
An emerging intervention is an intervention for which results of at least one study indicate 
potential favorable outcome, but overall the intervention lacks a base of high-quality research 
studies showing that the intervention is consistently effective in multiple independent trials. 
Based on the available evidence, emerging interventions cannot yet be designated as reliably 
effective or ineffective. Because more well established interventions are available, established 
interventions should be the treatments of choice, and parents should generally be dissuaded from 
relying too heavily on emerging interventions.  Many emerging interventions exist, including but 
not limited to: augmentative and alternative communication devices, developmental relationship-
based treatment, exercise, structured teaching, imitation-based intervention, initiation training, 
massage therapy, music therapy, picture exchange communication system (PECS), reductive 
package, sign instruction, social communication intervention, structured teaching, theory of mind 
training, and technology-based intervention. Interventions from this list are often used in 
conjunction with other strategies, such as using PECS for the individual to indicate a need or 
choice. Assessment of their efficacy may be complicated by their inclusion in a treatment 
program using established practices (NAC, 2015). However, at this point treatments in the 
“emerging interventions” category are not independently considered to be evidence-based 
practices.  
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Unestablished Interventions for Autism Spectrum Disorder  
Unestablished interventions have little to no evidence to support them in the scientific 
literature, and thus no firm conclusions can be drawn regarding effectiveness. For some 
interventions, multiple studies consistently disconfirm efficacy, and yet the treatments continue 
to be used by caregivers and even popularized by medical professionals. Many of the 
unestablished ASD interventions are relatively benign other the hassle involved (e.g., gluten-free 
diets) and possible high cost (e.g., auditory integration), but some unestablished interventions are 
potentially harmful. Unestablished interventions are bountiful, including but not limited to: 
animal assisted therapy, auditory integration training, concept mapping, floor time, facilitated 
communication, gluten-free/casein-free diet, movement-based intervention, theater intervention, 
sensory integration/sensory intervention package, shock therapy, social behavioral learning 
strategy, social cognition intervention, dietary supplements, acupuncture, homeopathy, and more. 
Some of these practices, such as gluten- and casein-free diets, are widely held to be efficacious 
by parents (Winburn et al., 2014) although the two large randomized clinical trials that tested 
their efficacy failed to show any positive effect  (Elder et al., 2006; Knivsbert, Reichelt, HØien, 
& NØdland, 2002). Reports of using dietary supplements (e.g., omega 3 fatty acids) are 
becoming more frequent, despite little scientific understanding of potential aversive effects of 
interactions between medications and many of the reported supplements (Levy & Hyman, 2008).  
 Some actions touted as interventions for ASD not only have little evidence of efficacy, 
but also carry significant risk of harm. These practices are not mentioned in the National 
Standards Project report, but chelation therapy (an invasive procedure that is medically indicated 
for confirmed heavy metal poisoning) and hyperbaric oxygen therapy (medically indicated to 
treat decompression sickness in scuba divers, or to treat wounds resistant to healing as a result of 
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diabetes or radiation injury) have been advertised as potential treatments or even cures for ASD. 
These invasive procedures place individuals at considerable risk, and yet some desperate (and 
perhaps ill-informed) caregivers have shelled out thousands of their own dollars chasing the 
chimeric “cure” for ASD. Some children have lost their lives as a result (Baxter & Krenzelok, 
2008; Brown, Willis, Omalu, & Leiker, 2006), thus underscoring the importance of 
understanding the factors underlying which treatments caregivers pursue and which interventions 
are eventually secured.  
Who Gets Which Services? 
In the body of literature surrounding EBP and non-EBP, a common phrase used to 
describe non-EBP is complimentary or alternative medicine (CAM). CAM approaches consist of 
various interventions not empirically validated for use in treating ASD. Interestingly, use of 
CAM approaches does not seem to be lessened with greater access to conventional treatments; 
rather, CAM use has been positively associated with receipt of 20 or more hours per week of 
conventional behavioral treatment (Akins, Krakowiak, Angkustsiri, Hertz-Picciotto, & Hansen, 
2014). Approximately half of caregivers of children with ASD in the US report use of CAM 
(Golnik & Ireland, 2009). Salomone and colleagues (2015) found a strong dose-response effect 
of use of conventional treatment and the concurrent use of mind/body CAM practices; parents 
who were using more than four conventional treatments were four times as likely to concurrently 
use CAM. This was not the case for those parents who used three or fewer conventional 
interventions (Salomone et al., 2015).   
Salomone and colleagues (2015) found approximately half (47%) of caregivers reported 
having used complimentary or alternative medicine (CAM) approaches to treat their children 
with ASD. Twenty-five percent of caregivers reported using dietary restrictions and/or 
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supplements, with another 24% of caregivers reporting use of mind/body practices such as 
sensory integration (14%), massage (7%), and homeopathy (10%). Pet therapy was endorsed by 
14% of caregivers (Salomone et al., 2015). The researchers found that 2.4% of parents endorsed 
using any “invasive, disproven, or potentially unsafe CAM” including chelation, hyperbaric 
chamber, and packing (being wrapped tightly for up to an hour in wet sheets that have been 
refrigerated). 
Salomone and colleagues (2015) found that predictors of dietary restriction and/or 
supplements included higher parent education level, low verbal ability in the child, and the use of 
prescription medications; child’s age, gender, or concurrent use of EBPs were not associated 
with increased likelihood of dietary restrictions or supplements. Mind/body practices including 
acupuncture, deep pressure therapy, massage, sensory integration therapy, and auditory 
integration therapy were more likely to be used by highly educated parents to treat female 
children with ASD; age, verbal ability, and concurrent use of medication were not associated 
with increased likelihood (Salomone et al., 2015). The finding that caregivers with higher 
education are more likely to use CAM is in concordance with previous research (Akins, 
Krakowiak, Angkustsiri, Hertz-Picciotto, & Hansen, 2014; Bernier, Mao, & Yen, 2010). While 
caregivers with higher educational achievement were more likely to use both types of 
interventions, the difference in use between higher and lower educated parents was most striking 
for mind/body interventions.  
Parents with a higher educational level may be more likely to use CAM / non-EBP 
simply because they are more likely to be able to afford them. Non-EBPs are not generally 
funded by insurance, and many involve direct provision of the therapy by the provider (e.g., 
massage, acupuncture, auditory integration), thus incurring substantial cost. These therapies are 
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on average approximately double the cost of dietary supplements and other interventions that 
parents can administer (Nahin, Barnes, Stussman, & Bloom, 2009).  In conclusion, the use of 
unestablished treatments (CAM) is common, usually in concert with one or more conventional 
ASD treatments (generally behavioral EBP, though types and definitions vary from study to 
study). Some factors are more predictive of one type of CAM use versus another, and a small 
minority of caregivers continues to pursue unsafe or dangerous practices despite active public 
campaigns against their use (Federal Drug Administration, 2014).  
Many primary care physicians of children with ASD report conversing with caregivers 
regarding biologically based CAM, such as dietary supplements (Golnik & Ireland, 2009). In a 
survey of 539 physicians, Golnik and Ireland (2009) found primary care physicians treating 
children with ASD encouraged the use of multivitamins (49%), essential fatty acids (25%), 
melatonin (25%), and probiotics (19%), and discouraged withholding (76%) or delaying (55%) 
immunizations, chelation (61%), and secretin (43%).  Many of the physicians in this survey 
reported a desire for additional training on available ASD treatments. This is promising as a 
focus for advancing accurate information regarding various therapies and relative risk/benefit 
ratios.  Professionals who work with individuals with ASD should recognize the likelihood that 
many of their clients are using CAM concurrently with EBP, and engage caregivers in 
discussions about CAM approaches, current state of the evidence, and potential for adverse 
effects as parents make treatment choices.  
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CHAPTER 4: BARRIERS TO ACCESSING ASD INTERVENTIONS  
Community and Cultural Factors 
Ethnicity may impact both the likelihood of receiving an ASD diagnosis and the age at 
which that diagnosis is given; these factors in turn may affect access to services and insurance 
eligibility. Differences in service use by individuals from minority racial or ethnic backgrounds 
have been found in multiple studies.  Latino or African American children with ASD are less 
likely to receive a diagnosis or to be diagnosed at a later age, thus missing out on important 
opportunities for early intervention to affect developmental trajectories (Mandell et al., 2009).  In 
the Mandell et al. (2009) study, African American children were diagnosed an average of 1.4 
years later than Caucasian peers.  Black / African American children may be more likely to be 
misdiagnosed than non-Latino white children. Mandell et al. (2009) found that black children 
were three times more likely to receive a different diagnosis, most often conduct disorder, before 
eventually receiving an ASD diagnosis. In this same study, Mandell and colleagues found that 
children of other minority groups, many of whom were recent immigrants, were more likely to 
be diagnosed with adjustment disorder before eventually receiving an ASD diagnosis. It is easy 
to conjecture that a diagnosis of conduct disorder or adjustment disorder would lead to very 
different types of intervention than if the child had initially received ASD diagnosis.  
Latino children are less likely to receive an ASD diagnosis than white non-Latino 
children (Liptak et al., 2008; Mandell et al., 2007; Palmer et al., 2010), and those who are 
diagnosed receive a diagnosis on average 2.5 years later (Mandell et al., 2002). Recently, Palmer 
and colleagues (2010) found that a 10% increase in the number of Latino children in a school 
district correlated with an 11% decrease in ASD diagnoses, but an 8% increase in ID diagnoses. 
These researchers contrariwise found that a 10% increase in non-Latino white children 
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corresponded with a 9% increase in ASD but an 11% decrease in ID (Palmer et al., 2010). 
Zuckerman et al. (2014) conducted focus groups with Latina mothers of Mexican origin to 
discuss perceived barriers to receiving timely diagnosis, and participants reported several cultural 
or community-specific factors. Parents stated that in their Mexican communities, the concept of 
ASD was practically non-existent, so a child who exhibited stereotypical ASD symptoms might 
be seen as being poorly behaved and unintelligent but without medical diagnosis (Zuckerman et 
al., 2014). Because unusual and potentially disruptive behaviors are not understood as being 
related to a disorder, the child’s behaviors may be seen as particularly shameful and indicative of 
poor parenting. Parents in this study also recalled significant stigma in their communities 
surrounding disabilities, particularly those related to mental health (Zuckerman et al., 2014). One 
mother recounted that in her hometown in Mexico, “parents ignore their children if they have 
some disability. . . If they are born with a deformed ear, they say, ‘this child isn’t worth 
anything,’ . . .or if they have a child in a wheelchair [and] . . .the mother goes outside the house 
to talk with someone selling something, she closes the door so no one can see him” (Zuckerman 
et al., 2014, p. 304).  Due to a lack of awareness of ASD, fear of being seen as a poor 
disciplinarian, and disability stigma, some parents reported feeling uncomfortable admitting or 
sharing their concern about their child’s behavior (Zuckerman et al., 2014). Some mothers 
reported machismo, traditional view of Latino male gender roles, as a particular problem for their 
partners. Mothers noted some fathers felt having a “weak” or “disabled” male child was a poor 
reflection on themselves, thus fathers might discredit mothers’ expressed concerns (Zuckerman 
et al., 2014). This could conceivably lead to disagreement about pursuing diagnostic services and 
lead to delays in treatment. While this study focused on a narrow range of participants (mothers 
of Mexican background), there are many areas of the world where the concept of autism is 
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nascent or entirely absent, as in many African countries (Ruparalia et al., 2016). Wherever there 
is a lack of understanding of ASD, there exists a risk of misconceptions about the etiology or 
significance of unusual behaviors to impede appropriate diagnosis and treatment.  
Unsurprisingly, language barriers present a significant obstacle to receiving timely ASD 
diagnosis in the United States when parents are not fluent in English.  Limited English 
proficiency contributes to difficulties with scheduling appointments and arranging transportation; 
limited access to qualified interpreters make it difficult for parents and clinicians to fully 
communicate and for parents to navigate the often multi-step diagnostic process (Zuckerman et 
al., 2014). In Zuckerman et al.’s (2014) study, Latina mothers reported concern that less-
acculturated parents are often afraid to speak up for fear of being seen unfavorably; these parents 
also may not know their child is eligible for certain services for which they could advocate, or 
that supportive services such as assistance with transportation to and from appointments are 
available.  It is also possible that in families where one or more members are undocumented 
immigrants, caregivers may be wary of getting involved in the diagnostic process or the pursuit 
of public insurance for the child despite reassurances of confidentiality due to concerns about 
how records may be accessed or used.  
Ethnicity impacts not only diagnostic but also treatment service access. In a study of 383 
families in North Carolina, Thomas and colleagues (2007) found racial and ethnic minority 
families had only half the odds of using a case manager and a quarter the odds of using a 
psychologist or developmental pediatrician as part of their child’s treatment. Rosenberg, Zhang, 
and Robinson (2008) found that in the United States, black children are only half as likely as 
white peers to receive early intervention services.  Zuckerman et al. (2014) found that Latina 
mothers reported purposefully avoiding seeking out services after an ASD diagnosis because the 
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diagnosis was so stressful and families had to adapt to the idea of the diagnosis before feeling 
ready to move on to the next step of accessing treatment. Reported stress from adjusting to the 
ASD diagnosis was related to the sense of stigma in having a child with a developmental 
disability (Zuckerman et al., 2014). While there has been an increase in research into ethnic 
factors related to ASD treatment in the past few years, overall there is a limited representation of 
ethnic and cultural minority participants in the research literature, especially pertaining to 
evidence-based interventions (West et al., 2016). 
Socioeconomic Status and Financial Barriers 
Despite state and federal efforts to make assessment and early intervention services 
accessible regardless of SES, differences still exist.  Durkin et al. (2010) found that those in the 
lowest third SES were half as likely to receive an ASD diagnosis as those in the highest third 
(Durkin et al., 2010). Interestingly, these statistics held true regardless of whether SES was 
measured by percent household income above poverty, parental educational attainment, median 
household income, or some combination (Durkin et al., 2010). Thomas et al. (2007) found that 
when parents had at least a college degree, families were 2-4 times more likely to use a 
neurologist, Picture Exchange Communication System (PECS), or therapeutic horseback riding, 
but overall no strong differences were noted in treatments used.  
Poverty exacerbates difficulties in receiving assessment services both directly and 
indirectly. According to one report, a child with ASD incurs approximately seven times greater 
health care costs than a child without ASD (Liptak, Stuart, & Auinger, 2006). Medical and non-
medical care costs for children with ASD are higher than costs for children with other 
developmental disabilities (Croen, Najjar, Ray, Lotspeich, & Bernal, 2006; Liptak, Stuart, & 
Auinger, 2006), particularly for children who do not have a medical home coordinating the care 
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(Kogan et al., 2008). Sharpe and Baker (2007) found that having a lower income was positively 
associated with having unreimbursed medical or therapy expenses, greater use of medical 
interventions, and forfeiture of future financial security (e.g., retirement, savings accounts). Even 
if insurance coverage is adequate, additional financial costs may be incurred due to the necessity 
of securing transportation, finding childcare for other children, or loss of hourly wages if 
caregivers must take time away from work. A child with ASD may require specialized care that 
excludes him/her from typical childcare settings, and may result in the necessity of one or both 
parents reducing work hours or one parent quitting a job (Gould, 2004). In a study of children 
with severe disabilities (a category including severe ASD symptomatology), Leiter et al. (2004) 
found that 20% of the caregivers sampled provided 20 hours per week or more of specialized 
health care themselves; half of the employed mothers had reduced work hours and half of non-
employed mothers had quit work in order to meet their child’s needs.  
Insurance 
Lacking insurance or having inadequate insurance coverage imposes a financial burden 
for accessing many services. Data from national surveys, private health insurance claims, 
managed care organizations, and state Medicaid programs point to a high rate of health care 
utilization by children with ASD, even when compared to children with other types of 
developmental disorders (Chatterji, Decker, & Markowitz, 2015). Utilization is especially high 
for psychiatric services and prescription medications (Chatterji, Decker, & Markowitz, 2015). 
Given that treatment plans for ASD tend to be multidimensional and highly individualized 
depending on the child’s symptom constellation and severity, treatment plans are often quite 
costly (Amendah et al., 2011).  Comparing children with and without ASD using data from the 
Medicare Expenditure Panel Survey and National Health Interview Survey, Lavelle and 
28 
 
colleagues (2014) found that after controlling for demographic factors and comorbid illnesses, 
children with ASD incurred an average of $3,020 additional health care costs and $14,061 
additional non-healthcare costs annually (including $8,610 additional school-related costs). It is 
noteworthy that this study was of children who were enrolled in Medicaid. The caregivers of 
children with ASD did not report significantly higher out-of-pocket costs or report spending 
more time on caregiving activities compared with the control group (Lavelle et al., 2014). It is 
possible that parents of children with private insurance have similar experiences, but no 
comparable studies across different private insurance providers are evident in the literature at 
present.  
Caregivers of children with ASD have reported greater challenges in accessing services 
and less overall satisfaction with services rendered when compared to caregivers of children with 
other special health care needs (Montes, Halterman, & Magyar, 2009). Insurance plans generally 
exclude some types of ASD treatments, especially behavioral treatments (Chatterji, Decker, & 
Markowitz, 2015), even though several behavioral treatments are efficacious for treating ASD-
related challenges (NAC, 2015). With many states having recently mandating ASD coverage for 
most insurance plans, these exclusions are fortunately on the decline, though extent of 
reimbursement may still be quite limited. 
 Thomas et al. (2007) surveyed 383 families of children with ASD, and found that 
children covered by Medicaid or other public insurance had 2 to 11 times the odds of using the 
following compared to children covered by private insurance: medication management, 
therapeutic support services including respite care and case managers, Picture Exchange 
Communication System (PECS), and speech/language therapy. These same children were only 
one quarter as likely to use dietary supplements as those on private insurance. Perhaps 
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surprisingly, children who lacked health insurance were more likely to receive services that 
facilitated entry into the health care system (e.g., case manager, developmental pediatrician; 
Thomas et al., 2007). More recently, Parish and colleagues (2014) found that on average, 
families of children with ASD spent approximately 4.1% of income per capita on their child’s 
health care.  After controlling for symptom severity and demographic characteristics, families 
with private insurance were more than five times as likely to have out-of-pocket expenditures for 
ASD treatment compared to families of children covered by public health insurance. The most 
frequently cited out-of-pocket costs were medications, outpatient services, and dental care 
(Parish, Thomas, Williams, & Crossman, 2014). The disparities between private and public 
insurance in these studies indicate significantly greater financial burden for children covered by 
private insurance. 
To ease the financial burden of ASD, now recognized as the second-most common 
developmental disability in childhood (behind intellectual disability; Newschaffer et al., 2007), 
many states have recently mandated insurance coverage of ASD-related services. As of 
September 2015, 42 states have passed laws that require many private health insurance policies 
to include diagnostic and treatment services for ASD (American Speech-Language-Hearing 
Association, 2015). It is unclear how efficacious these mandates have been in reducing out-of-
pocket expenses or expanding access to treatment as very little data has yet been published on 
the effects. Johnson, Danis, and Hafner-Eaton (2014) studied the variation of insurance coverage 
across the United States of America at a time that 30 of the states mandated private insurers to 
cover behavioral therapy for autism. The authors found that rather than decreasing the disparity 
in service accessibility between states, the states that had passed insurance mandates at that time 
were those in which services were already more readily available prior to the new legislation 
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(Johnson, Danis, & Eaton, 2014). The authors concluded that the mandates resulted in an 
increase in the disparity in service accessibility between more advantaged and less advantaged 
states. In a study of the 37 states with ASD insurance mandates at the time, Chatterji and 
colleagues (2015) found ambiguous results regarding the mandates’ effect in reducing out-of-
pocket spending and increasing access to services; no statistically significant association between 
state ASD mandates and caregiver report of financial burden, access to care, or unmet need for 
services was found. The authors noted that the effect of such a mandate likely varies state to state 
based on the percentage of the working population included, and further research is needed in 
this area. 
Geography 
Geographical location also factors into the likelihood of a diagnosis and access to 
services. As an example, Louisiana’s Office for Citizens with Developmental Disabilities 
acknowledged geographical disparities in ease of access to services provided by its statewide 
early intervention program for toddlers with developmental delays. Despite considerable efforts 
to reach all areas of the largely rural state, OCDD reported concern over a shortage of providers 
in particular disciplines, as well as a shortage of providers in general in rural areas (OCDD, 
2013). This is only one example; other states likely experience similar difficulties in providing 
services with equanimity in the face of financial restrictions and uneven distribution of qualified 
providers across regions.  
Urban areas with greater density of medical professionals and with closer proximity to 
medical services may have an advantage in providing diagnostic and treatment services, thus 
mitigating the effect of some other factors often associated with variability in service access. For 
example, a population-based study conducted by the CDC in urban Atlanta found no influence of 
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race, ethnicity, or sex on the age of diagnosis, but that age of diagnosis was affected by degree of 
impairment (Wiggins, Baio, & Rice, 2006). In this study, children with ASD were initially 
evaluated at an average of 48 months and received a diagnosis 13 months later (Wiggins, Baio, 
& Rice, 2006). Kalkbreener et al. (2011) found similar results, with the majority of children 
living in urban areas having better access to services and receiving diagnoses at an earlier age. 
Thomas et al. (2007) found that when families lived in nonmetropolitan areas, children with 
ASD had reduced odds of two treatments in particular: attending summer camp (Odds Ratio = 
0.33), and using respite care (Odds Ratio = 0.21).  
Systemic Barriers 
Possible barriers at the systemic level may include failure to incorporate appropriate 
screenings into pediatric wellness visits, reluctance of pediatricians to refer young children, or 
children with less severe symptoms, or lack of coordination between various agencies. Children 
in child protective services, or otherwise part of child welfare systems, are often under-identified 
with regard to developmental delays including ASD (Berkoff, Leslie, & Stahmer, 2006). The 
number of pediatricians available in a given area may play a role in identifying rates of ASD 
(Mandell & Palmer, 2005), as do medical and educational system funding levels, which affect 
ability to train providers (Mandell & Palmer, 2005). Sices et al. (2004) found that the type of 
behavior exhibited in the pediatrician’s office had a greater influence on determining referral for 
diagnostic services than did parents’ initial concerns about their child’s development, including 
day to day behavior at home. In this same study, female medical doctors were more likely than 
males to refer a child to a specialist for evaluation (Sices et al., 2004).   
Zuckerman et al. (2014) found that many Latina mothers reported losing faith in 
healthcare providers throughout the diagnostic process, which was often described as lengthy 
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and intensely stressful. Declining trust in the healthcare system was related to length of time over 
which the diagnostic process extended; mothers reported that as time went on they began 
doubting whether providers were delivering care in the best interest of the child, and wondering 
if providers were purposefully increasing the difficulty of service access (Zuckerman et al., 
2014). Some mothers reported feeling as if the diagnostic visit was primarily for conducting 
research, rather than for providing thoughtful recommendations or helpful resources. The results 
of Zuckerman et al.’s (2014) study fit with research reports that ethnic minority families receive 
less guidance and experience increased obstacles when pursuing heath care in general (Jimenez, 
Barg, Guevara, Gerdes, & Fiks, 2012; Zuckerman, Perrin, Hobrecker, & Donelan, 2013). 
Distrust in the medical system could erode a caregiver’s willingness to continue on despite the 
stresses of navigating the healthcare system in pursuit of treatment.   
Characteristics of Early Intensive Behavioral Intervention (EIBI) 
Sometimes the very nature of the intervention presents barriers to participation, such as 
the time demands and often-intrusive nature of in-home EIBI. EIBI is, by definition, intense in 
nature, often multiple hours per day for most days of the week. Although EIBI is widely 
recognized as one of the most fruitful interventions for young children with ASD, and likely 
results in better prognosis and cost savings in the long term, in the short term these programs are 
very expensive (up to $30,000 per year; Sharpe & Baker, 2007). Many insurance policies will 
not pay for the entire 20-40 hours per week that these programs generally recommend. 
Accordingly, providing EIBI for a child with ASD often imposes great financial burden on 
families, even those with medical insurance. EIBI services are often delivered in the individual’s 
home, though they may be provided at a school or therapy center. When they are provided in the 
home, several therapists may regularly frequent the home; this may present a problem for some 
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families who highly value privacy. Scheduling constraints may be problematic if a primary 
caregiver is required to be home during all therapy hours.  
Johnston and Hastings (2002) analyzed barriers to the implementation of ABA-based 
EIBI programs for ASD, concluding that barriers experienced by families fell into the following 
categories: characteristics of particular service providers (e.g., policies, lack of resources, long 
wait lists) or their staff (e.g., lack of training and skill), the nature of the programs (e.g., slow to 
produce noticeable change, perceived inflexibility), and external factors (e.g., family factors).  
The researchers found that the largest percent (70.9%) of 141 families of children with ASD 
reported difficulty developing or maintaining a treatment team; these families perceived that 
problems with staff shortages or lack of appropriate training for staff constituted a significant 
barrier. Of note, this study was conducted in the United Kingdom at a time when ABA-based 
programs were relatively new to the ASD treatment scene. The authors noted a paucity of well-
trained supervisory staff, which they conjectured may not be as large a barrier in the United 
States where EIBI has been widely promoted for a longer period of time (Johnston & Hastings, 
2002). Other common barriers to implementing intensive behavioral intervention included 
difficulty in funding services (68.1%); and personal/family constraints such as amount of time 
required, scheduling around other family members, or other obligations (42.6%). Johnson & 
Hastings’ (2001) list of perceived barriers to EIBI also included problems with educational 
systems such as negative attitudes or unwillingness to provide services (17.7%), negative impact 
on families such as disruption of family life or feeling that home space was invaded (13.5%), 
lack of support from specific schools or teachers (9.2%), child-specific concerns such as illness 
or lack of concentration (5.7%), and lack of physical resources (e.g., necessary equipment or 
space) in home (5.0%; Johnson & Hastings, 2001). In this same study of barriers to ABA-based 
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early intervention programs, Johnson and Hastings (2001) found that facilitators of participation 
in ABA-based programs included perceptions of having a stable, supportive care team (75.9%); 
being motivated by observable progress (26.2%); flexible work schedules (4.3%), and a number 
of other factors falling broadly under “social support” (e.g., support of family, friends, support 
groups, and/or school faculty). 
Comorbid Conditions 
 ASD used to be considered as a singular condition; however, research has evolved our 
understanding of etiology of autism, and researchers have demonstrated that ASD commonly 
occurs with other psychopathology (Matson & Nebel-Schwalm, 2007; Smith & Matson, 2010a, 
2010b, 2010c).  Children with ASD have a high rate of other mental and physical difficulties, 
with some estimates as high as 80% or more having psychiatric comorbidity (Joshi et al., 2010; 
Kogan et al., 2009; Matson & Nebel-Schwalm, 2007). In a study of families of children with 
ASD only and children with ASD plus a comorbid psychiatric condition, Ahmendani and Hock 
(2012) found higher overall healthcare utilization among the 66.2% of participants with 
comorbid conditions, but these families were also more likely to be dissatisfied with care, 
dissatisfied with coordination between providers, and to report delay or non-receipt of needed 
services. Delay or non-receipt of services was most likely for children with comorbid depression 
or conduct problems. The most frequently cited reasons for delaying or not receiving treatments 
among those with comorbid conditions were out-of-pocket cost and denials of coverage by 
insurance. Delays were also likely when parents perceived that providers did not communicate 
effectively with the parent and did not make the parent feel like a partner in care (Ahmendani & 
Hock, 2012). Children with comorbid conditions may be more likely to need services from 
multiple locations, contributing to the challenges of coordinating care among providers, and 
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paying via multiple sources (e.g., public, private, self-pay). The increased challenges to receiving 
care in Ahmendani and Hock’s (2012) study provide evidence that the existence of comorbidities 
predisposes one to experience greater challenges in meeting health care needs, but does not 
provide a direct link between the presence of a comorbid condition acting as the limiting factor 
in receiving treatment. However, it is not difficult to imagine scenarios in which challenging 
behavior could be prohibitive to intervention. For example, a child who becomes very aggressive 
when angry or engages in unsafe behaviors in the car may cause parents to second guess their 
ability to safely take their child to the session, or weigh the long-term gains against the short-
term struggles.  
Burden of ASD Diagnosis 
The process of obtaining an ASD diagnosis can be complex and time-consuming; once a 
diagnosis is given, parents and caregivers face additional future stressors related to navigating 
health, educational, and other service systems for their child. The direct costs of medical and 
nonmedical services plus indirect costs such lost opportunities and income for individuals with 
ASD and their families have been estimated to total approximately $3.2 million per child in the 
United States (Ganz, 2006). The emotional burden of caring for a child with ASD can be 
significant for the entire family. Compared to families of children with ASD, families of children 
with special health care needs (CSHCN) who do not have an ASD diagnosis are significantly 
less likely to report problems with referrals, coordinating care, and obtaining family support 
services (Kogan et al., 2008). Parents must often shoulder the burdens of physical and emotional 
stress, divorce, and job loss, which then impact the entire family system (Baker-Ericzen, 
Brookman-Frazee, & Stahmer, 2005; Bromley, Hare, Davison, & Emerson, 2004; Hastings et al., 
2005; Järbrink, Fombonne, & Knapp, 2003).   
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Early identification can lead to better outcomes for children and families if identification 
leads to receipt of appropriate intervention services and supports for the family (Council on 
Children with Disabilities, 2006), but when parents have to act as coordinators for intervention 
services across several disconnected systems (healthcare, education, social services, transition 
services upon starting school and aging out of child-focused services), there are many potential 
barriers that can stymie the parents’ efforts. Investigating the difficulty of coordinating care, 
Carbone, Behl, Azor, and Murphy (2010) noted that pediatricians reported little to no dialogue 
with school systems for the purposes of developing intervention plans. The researchers noted 
lack of uniform eligibility requirements for interventions that were not integrated across the 
several different systems serving the family. “This lack of coordinated care,” they stated, “results 
in confusion for families, mixed messages from different treatment providers, and promotes 
adversarial relationships between various disciplines” (Carbone et al., 2010, p. 322). Woodgate, 
Ateah, and Secco (2008) found that many parents described their contact with various systems as 
patently unsupportive. Thomas, Ellis, McLaurin, Daniels, and Morrissey (2007) found that 
parents who reported greater family stress were more likely to engage in intervention services. 
Other researchers have found that the struggle to access services is a significant stressor for 
families of children with autism, due to a variety of barriers including financial cost and limited 
availability (Mackintosh, Goin-Kochel, & Meyers, 2012).  
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CHAPTER 5: PURPOSE 
Disparities in service use indicate a need to develop policy, practice, and family-level 
strategies to address barriers to ASD services. Research about how families experience diagnosis 
and coordination of intervention services, along with perceived barriers and facilitators, can 
inform the development of efforts to this end. Federal and state policies and practices within 
service systems will be better able to improve with understanding of their clients’ experiences. 
The goal of this study is to investigate current patterns in perceived barriers experienced in 
accessing both diagnostic and intervention services, including the most significant barriers 
associated with evidence-based interventions.  
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CHAPTER 6: METHOD 
Participants 
Inclusion criteria for this study included self-identified caregivers of individuals with an 
ASD diagnosis (Autism Spectrum Disorder, Asperger’s Disorder, PDD-NOS, or Autistic 
Disorder) who completed an online survey (see Appendix A) and reside in the United States of 
America. Participants were recruited through information distributed to health care clinics, 
parent advocacy/support groups, outpatient therapy clinics, and similar organizations. A total of 
150 individuals began the online survey. Participants were excluded from analyses for the 
following reasons: Selected “Decline to participate” after reading introductory page and 
confidentiality information (n = 1), dropped out during initial demographics questions (n = 58), 
diagnosis listed as something other than ASD (i.e., “sensory processing disorder,” (n = 2), or 
misunderstanding the questionnaire (n = 1) in the case of an employee at a residential center who 
attempted to complete the survey about multiple clients in general rather than a single 
individual). This left a total of 88 participants to be included in analyses, with a dropout rate of 
42.33%. This is somewhat higher than the roughly 30% dropout rate often observed in shorter 
online surveys (Galesic, 2006), but Galesic found a similar dropout rate for a similar study of 
41.8% for an online survey without compensation of similar length (180 questions) in a study of 
effects of interest and burden affecting dropout rates on online surveys. It is likely that a shorter 
survey would have had a higher completion rate, but the completion rate is within the expected 
range given the characteristics of the survey. 
The 88 participants whose data were retained for analysis reported residing in 20 
different states, with the states most frequently represented including South Carolina (n = 18), 
Louisiana (n = 9), Pennsylvania (n = 8), and Indiana (n = 6).  The majority of participants were 
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parents (69 mothers, 5 fathers) or grandparents (n = 7) of individuals with ASD; other 
participants included miscellaneous caregivers, generally other relatives (n = 6). Demographic 
information for the caregiving participants and families is presented in Table 1. Breakdown of 
participants by research question can be found in Appendix D, as not all participants were 
included in all questions for various reasons (e.g., dropout, had not begun receiving treatment 
yet, etc.). 
Table 1. Demographic Information for Caregivers and Families (N = 88) 
Demographic n (percent) 
Caregiver’s Ethnicity 
White 
African American 
Latino 
Asian 
Other 
Combination  
      Declined Answer 
 
75 (85.23) 
4 (4.54) 
1 (1.13) 
2 (2.26) 
0 (0.00) 
4 (4.54) 
2 (2.26) 
 Child’s Ethnicity 
White 
African American 
Latino 
Asian 
Other 
Combination 
      Declined Answer 
 
70 (79.54) 
4 (4.54) 
1 (1.13) 
0 (0.00) 
2 (2.26) 
10 (11.36) 
1 (1.13) 
 Caregiver’s Gender 
Male 
Female 
       Decline Answer 
Child’s Gender 
       Male 
       Female 
 
 
6 (6.81) 
81 (92.04) 
1 (1.14%) 
 
68 (77.27) 
4 (4.54) 
 Reported Diagnosis 
Autistic Disorder 
PDD-NOS 
Asperger’s Disorder 
ASD  
 
18 (20.45) 
12 (13.64) 
7 (7.95) 
51 (57.95) 
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Measures 
Survey 
An online survey was conducted to collect all required information from participants. 
After informed consent was given, the second page of the survey took the participant to a page 
with questions about demographic information. Questions included demographic information for 
both caregiver and child, questions surrounding diagnostic and treatment service use and access, 
and a measure of autism symptom severity (the Autism Spectrum Disorder-Diagnostic for 
Children). The survey was designed such that all questions must be answered before the 
participant can go on to the next page to decrease likelihood of missing data; however, “other, 
write in” and “prefer not to answer” options were utilized in case participants found the provided 
options to be insufficient.  
Before recruitment for the study, a group of 8 parents served as a pilot group for the 
survey. Three of these parents were primary caregivers for individuals with ASD and one was a 
parent of a young child with special needs. Minor wording and formatting changes were made in 
accordance with feedback from the pilot study prior to active recruitment. The survey was 
designed in and administered through Qualtrics; see Appendix A for more detailed survey 
information.  
The first page of the online survey was the consent form, which informed participants 
that information collected would be devoid of personally identifiable information (PII), outlined 
measures to ensure data security, reminded participants that they could exit the survey at any 
time by closing the survey window. They were also notified that they could withdraw all 
previously entered data by contacting the researchers at the provided email, and provided the 
email contact of the researchers and the LSU IRB in case any further information was desired. 
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The last page of the survey included information on what to look for when pursuing ASD 
interventions, information on evidence based versus non-evidence based practices, and links to 
reputable sources of information, followed by contact information for the researchers for any 
follow-up questions.  
Autism Spectrum Disorder-Diagnostic for Children (ASD-DC) 
The ASD-DC (Matson & González, 2007) is a 40-item, informant-based rating scale to 
assess ASD under the DSM-IV-TR diagnostic criteria. The ASD-DC was designed to be a cost- 
and time-efficient measure of symptoms associated with Autistic Disorder, Pervasive 
Developmental Disorder Not Otherwise Specified (PDD-NOS), and Asperger’s Disorder, all 
considered Autism Spectrum Disorders under the DSM-IV-TR criteria. It is the diagnostic portion 
of a four-part assessment battery (the Autism Spectrum Disorder- Child Version; Matson & 
Gonzalez, 2007 a, b, c); the full battery is designed to also assess comorbid symptoms and 
problem behaviors in children ages 2-16 suspected of having an ASD. The battery also includes a 
direct observation portion for the clinician to use in conducting a brief observational play session 
with the child. For this study, only the caregiver report section assessing ASD symptoms, the 
ASD-DC, will be used. In this measure, the clinician reads the items to caregivers, who are asked 
to rate the items on a 4 point scale in which they compare the behavior of their child with the 
behavior of typically developing, same-aged peers and rate the item for “extent that it is/was ever 
a problem” as follows: 0 = “not different; no impairment”; 1 = “somewhat different; mild 
impairment”; 2 = “very different; severe impairment.”  Although typically the clinician reads 
each item for this measure, for the purposes of this survey, caregivers will read each item 
themselves as part of the survey.  
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According to factor analysis, the ASD-DC measures behaviors on four factors 
corresponding with areas impaired by ASD symptoms: nonverbal communication/socialization, 
verbal communication, social relationships, and insistence of sameness/restricted interests 
(Matson, Boisjoli, & Dempsey, 2009). Internal consistency of the measure is .99 and test-retest 
and inter-rater reliability are satisfactory at κω=. 77 and κω=. 67, respectively (Matson, 
Gonzales, Wilkins, & Rivet, 2008). The measure has good sensitivity and specificity to 
diagnose ASD with total correct classification rates between typically developing children and 
atypically developing children/possible ASD of 84.3%, and between atypically developing 
children/possible ASD and children with probable ASD at 87.8% (Matson, González, & 
Wilkins, 2009). Cronbach’s alpha for this particular sample was computed (40 items, α = 0.94), 
with results indicating a high degree of internal consistency for this sample.  
Procedure 
Prior to participant solicitation, the research procedures and protocol were approved by 
the Louisiana State University Institutional Review Board (see Appendix C for IRB approval). 
Participants were recruited via posts to electronic forums (e.g., Facebook, Twitter, Reddit, 
Postwaves, NextDoor), newsletters from state and regional Autism Society chapters, fliers posted 
at a variety of places likely to be frequented by caregivers of children with ASD (e.g., doctor or 
therapy provider offices, community centers), and word of mouth. An effort was made to 
distribute across a wide geographic area (e.g., multiple states, national online forums), 
particularly to organizations known to provide free or low-cost services (e.g., state organizations 
that offer free/low cost diagnostic services to state citizens and treatment costs on a sliding scale) 
in order to attract participants across a wider range of SES. Use of internet-only survey was 
deemed appropriate due to rapid increases in internet access across demographics in recent years. 
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According to a 2013 Pew Research study, only 15% of Americans do not regularly use the 
internet; half of these individuals stated that they do not use the internet because it is “irrelevant 
to them” rather than citing access/financial barriers. Based on past trends, it is likely that in the 
three years since this study was published, an even greater percentage of individuals regularly 
access the internet, and that internet access would not pose a significant barrier to completion of 
this survey (Pew Research Center, 2013).  
 Recruitment information included inclusion criteria (i.e., primary caregiver of individual 
with diagnosis of Autistic Disorder, Asperger’s Disorder, Pervasive Developmental Disorder not 
otherwise specified, or Autism Spectrum Disorder) and a brief description of the type of 
information sought (i.e., information related to treatments utilized, difficulty accessing services, 
and demographic factors devoid of personally identifiable information).  Recruitment 
information stated that no compensation would be provided for survey completion and included 
a link to the online survey. No incentive was offered due to inability to reliably screen out 
participants who might complete the survey multiple times. Estimated time to complete the study 
based on pilot testing was also included. 
 The information necessary for this study was collected via an online survey set up 
through Qualtrics, a company with software by the same name used for online research data 
collection and analysis. See Appendix B for detailed information regarding Qualtrics privacy 
policies, certifications, and security measures. Louisiana State University currently has a contract 
with Qualtrics, through which account the survey data was collected. After reading the consent 
form, participants manually selected an acknowledgement button indicating they read and agreed 
with the statements outlined in the consent form. Participants then completed the survey, which 
collected the information outlined in Appendix A. Once data from a sufficient number of 
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participants was collected, data was imported from Qualtrics into Statistical Package for the 
Social Sciences (SPSS; IBM Corporation, 2013) for analysis. 
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CHAPTER 7: HYPOTHESES 
A series of analyses were performed to address several research questions: What are the 
most commonly reported perceived barriers to diagnostic services? What are predictors of 
experiencing the greatest number of perceived barriers to diagnostic services? What are 
predictors of professional reassurances and family factors as perceived barriers to diagnosis? 
What are the most commonly perceived barriers resulting in discontinuation of previous 
interventions? What are the predictors of reporting the greatest number of barriers causing 
discontinuation of EPBs? What factors predict length of time between diagnosis and receiving 
treatment for ASD? What interventions are currently most desired? Finally, what factors are 
predictive of caregivers hoping to obtain EBP over non-EBP?  
It was expected that wait list for diagnostic services would be the most commonly 
reported barrier to diagnosis. It was hypothesized that living in an urban area, higher household 
income, higher educational attainment, and greater ASD symptom severity would be correlated 
with fewer reported barriers to diagnostic services, whereas identifying as an ethnic minority 
would be correlated with an increase in barriers, perhaps in part due to correlation in the United 
States between minority status and greater barriers to achieving higher education and income. It 
was hypothesized that increased ASD symptom severity would correspond with a decreased 
likelihood of perceiving professional reassurances as a barrier to diagnosis, and also 
hypothesized that increased education of parents would also correspond with a decrease in 
perceiving this barrier, as more educated parents may be better able to engage researching 
symptoms prior to appointments, thus able to speak more precisely about their child’s symptoms 
and ask more pointed questions about autism-specific concerns. Based on literature reviewed in 
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the section on Community and Cultural Factors, it was hypothesized that ethnicity would impact 
likelihood of perceiving caregiver disagreement as a barrier to diagnosis.  
With regard to interventions, it was hypothesized that changes in eligibility would be the 
most frequent cause of discontinuation for early intensive behavioral interventions due to the 
nature of the state- and federally-funded programs to target children in early childhood and 
younger to receive these subsidized services. With regard to EBP and non-EBP in general, it was 
hypothesized that while out of pocket cost would be a significant barrier, it would be more 
highly cited as a cause for discontinuation of non-EBP services due to decreased likelihood of 
insurance reimbursement for such services. Similarly to hypothesized results for barriers to 
diagnosis, it was hypothesized that lower household income would predict higher numbers of 
reported barriers to EBPs. It was also hypothesized that rural indication would also be correlated 
with higher number of barriers to EBPs, while higher ASD symptom severity would be 
correlated with fewer barriers. With regard to gap between diagnosis and treatment, it was 
hypothesized that ethnicity would be most highly correlated with a gap between diagnosis and 
treatment, with minorities experiencing the greatest gap. With regard to desired future EBPs, it 
was expected that the barriers would follow the same trends found for reasons for discontinuing 
past EBPs, with cost being highly ranked as a barrier. It was also expected that difficulties with 
scheduling would also rank highly, since many treatment centers operate during normal working 
hours (9am-5pm) and it could be that services had not yet been accessed due to difficulty with 
parent work schedules or interference of time required for desired therapies conflicting with 
currently received services or school. 
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CHAPTER 8: STATISTICAL ANALYSES 
First, preliminary analyses were conducted to determine the sample size needed to 
answer the research questions. Second, descriptive analyses were run to provide additional 
demographic information (e.g., income, insurance type, education level of caregivers). The third 
set of analyses included descriptive analyses of factors related to perceived barriers to diagnostic 
services, followed by a multiple regression to investigate factors related to reporting a greater 
total number of barriers to diagnostic services. The author was particularly interested in factors 
predicting barriers that could potentially be addressed with targeted educational initiatives (e.g., 
education for healthcare professionals or families to address related barriers). Accordingly, a 
logistic regression was run to investigate factors related to professional provider reassurances as 
a reported barrier to diagnostic services. Chi-squared test was run to investigate whether 
identifying as being of ethnic minority status was correlated with increased likelihood of family 
disagreement as a barrier to diagnostic services.   
The fourth set of analyses investigated barriers to previously tried interventions that 
resulted in discontinuation of interventions. Descriptive analyses outline the discontinued 
treatments and barriers experienced to EBPs and non-EBPs. Multiple regression was used to 
investigate predictors of experiencing greater number of barriers resulting in discontinuation of 
EBPs. As insurance coverage is closely related to the out of pocket costs of treatment, follow-up 
testing via Kruskal-Wallis analysis was conducted to investigate the relationship between 
insurance type and number of perceived EBP barriers reported.   
Fifth, multiple regression was used to investigate whether various demographic factors 
predicted variations in time between receiving a formal ASD diagnosis and treatment of ASD 
symptoms.  
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Sixth, the author inspected the answers of those participants who had indicated a current 
desire to pursue additional interventions for their child with ASD. A total of 51 participants 
indicated they were either in the process of gaining access or were preparing to soon attempt to 
access additional interventions. Of these, 41 participants gave answers that could be categorized 
into EBP or non-EBP practices. Descriptive analyses provided information regarding perceived 
barriers to desired interventions. A binomial regression was utilized to inspect factors related to 
whether a participant who desired additional services was seeking EBP vs. non-EBP treatments. 
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CHAPTER 9: RESULTS 
Preliminary Analysis 
G*Power 3, a power analysis computer program (Faul, Erdfelder, Lang, & Buchner, 
2007), was used to determine the sample size needed for the analyses with the greatest number of 
planned variables (regression analyses on factors affecting number of  perceived barriers 
reported). A medium effect size of ƒ2  = 0.2, power of .80, and alpha of .05 were used. These 
methods are conventional and accepted levels for use in psychological research for alpha and 
power (Cohen, 1988; Hinkle, Wiersma, & Jurs, 2003).  A medium effect size was also chosen 
due to the widely varying results of studies investigating various factors associated with barriers 
to ASD services. The power analysis indicated a minimum of 75 participants would be sufficient 
for the planned analyses.  
Descriptive Analyses 
 The first set of analyses provided descriptive information for the participants and their children 
with ASD. The majority of participants lived in urban areas (50,000+ residents), and only 8 
resided in rural areas (less than 2,500 people). The majority of the sample had family incomes of 
70,000 or more and an unusual number had some graduate school education (n = 30; 34.10%). 
Additional demographic details are presented in Table 2.  
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Table 2. Additional Demographic Details (N = 88) 
Demographic n (percent)  
Geography of Residence 
        Urban 
 
38 (43.18) 
Suburban 42 (47.72) 
Rural 8 (9.09) 
Family Income*  
<10k 
10k-25k 
25k-40k 
40k-55k 
55k-70k 
70k-100k 
>100k 
Declined Answer 
 
 
7 (7.95) 
5 (5.68) 
6 (6.82) 
14 (15.91) 
11 (12.50) 
20 (22.73) 
18 (20.45) 
7 (7.95) 
Child’s Insurance Type 
Private Only 
Public Only 
Private and Public 
None 
Not Sure/Declined  
 
30 (34.09) 
27 (30.68) 
24 (27.27) 
0 (0.00) 
7 (7.95) 
Caregiver Education  
Some high school  
High school graduate 
Technical degree 
Some college 
College graduate 
Some graduate school 
Graduate degree 
 
2 (2.27) 
5 (5.68) 
8 (9.09) 
13 (14.77) 
30 (34.09) 
2 (2.27) 
28 (31.82) 
Caregiver Marital Status 
         Single 
         Married or Cohabiting 
         Separated/Divorced 
         Widowed 
       Not sure/decline 
 
8 (9.09) 
62 (70.45) 
14 (15.91) 
4 (4.54) 
0 (0.00) 
*k = $1,000 US Dollars  
Mean ASD-DC scores ranged from 58-119 (M = 92.36, SD = 14.79). Of note, 20 
individuals were out of the age range of 2-16 years for which the ASD-DC was normed. 
Excluding these 20 individuals, total ASD-DC scores were virtually unchanged, ranging from 
59-118 (M = 92.25, SD = 14.06). 
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Current ages of participants’ children with ASD ranged from 1.5 years to 32 years (M = 
11.49; SD = 6.52). Age at diagnosis ranged from 1 to 21 years (M = 4.70; SD = 3.87). Many 
individuals (N = 24) reported their child began receiving therapy to treat ASD symptoms before 
actually receiving a formal ASD diagnosis. Age at first treatment for ASD symptoms ranged 
from 1 year to 18.5 years (M = 4.24; SD = 3.35). Four participants reported they have not yet 
been able to access treatment services. Twelve individuals reported beginning treatment within 
one month of receiving diagnosis. Of those who experienced a delay between diagnosis and 
treatment, time delay ranged from one month to 31 months. (M = 5.42; SD = 7.36). Time elapsed 
between diagnosis and completion of survey were computed to be used as a covariate in analysis 
on discontinued treatments; time ranged from 0 months to 278 months (M = 80.27; SD = 70.89).  
Additional information regarding ages and time delay is presented in Table 3. 
Table 3. Age / Time Information 
Occasion N In Months 
M (SD) 
In Years 
M (SD) 
Child’s Age:  
Present 
At Diagnosis 
First Treatment* 
 
88 
88 
84 
 
137.93(78.27) 
56.39 (46.45) 
50.90 (40.16) 
 
11.49 (6.52) 
4.70 (3.87) 
4.24 (3.35) 
Time Lapse  
Diagnosis to Treatment* 
Gap Diagnosis to Treatment** 
Diagnosis to Present 
 
84 
60 
88  
 
 
5.42 (7.36) 
80.27 (70.89) 
 
 
--- 
6.70 (5.91) 
 
*Excluded individuals who have not begun receiving treatment yet (n = 4) 
**Excluded individuals who have not begun receiving treatment (n = 4) or began  
receiving treatment prior to diagnosis (n = 23).  
 
Perceived Barriers to Diagnostic Services 
Descriptive Analyses  
The most frequently reported perceived barriers to diagnostic services were long 
waitlists, reassurances from professionals that the child would “grow out of it” or that symptoms 
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were due exclusively to some comorbidity (e.g., intellectual disability, Down Syndrome, partial 
agenesis of the corpus callosum), and difficulties with scheduling. Out of the 88 participants, 75 
reported experiencing at least one barrier to receiving diagnosis. Many families experienced 
multiple barriers to diagnosis. Overall, caregivers reported a mean of 1.68 (SD = 1.38) perceived 
barriers to diagnosis, with a range of 0-7 barriers experienced. Additional details regarding 
barriers to diagnostic services can be seen in Table 4. 
Table 4. Perceived Barriers to Diagnostic Services (N = 88) 
Barrier n Percent 
Wait list 
Transport/Proximity 
Scheduling 
Cost  
Family  
Practitioner Reassurances 
Other 
None 
49 
6 
19 
15 
14 
33 
12 
13 
55.68 
6.82 
21.59 
17.05 
15.91 
37.50 
13.64 
14.77 
 
Predictors of Greatest Number of Past Barriers  
Multiple regression was used to investigate factors related to experiencing greater 
numbers of perceived barriers to diagnostic services. Investigated factors included geography 
(living in urban, suburban, or rural areas), family income, ethnicity (minority or not), caregiver 
education level, and ASD-DC Total Score. All factors were entered simultaneously. As 
previously noted, 20 of the ASD-DC scores were for individuals outside of the designed age 
range (2-16 years). To account for this, the analysis was run both with and without these 
individuals included. Results of both analyses are reported below.  
All participants included. Overall, caregivers experienced a mean of 1.68 (SD = 1.38) 
perceived barriers to diagnostic services. There was linearity as assessed by partial regression 
plots and a plot of studentized residuals against the predicted values, and independence of 
residuals as assessed by a Durbin-Watson statistic of 2.16. There was homoscedasticity, as 
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assessed by visual inspection of a plot of studentized residuals versus unstandardized predicted 
values. There was no evidence of multicollinearity, as assessed by tolerance values greater than 
0.1. There was one studentized deleted residual greater than ±3 standard deviations for an 
individual reporting 7 of 10 possible barriers to diagnosis (studentized residual = 3.51), but 
inspection of the data point indicated no probable error in data entry or other reason for removal, 
and leverage value of 0.112 was within the acceptable range so this data point was maintained. 
There were no leverage values greater than 0.2, and were no values for Cook's distance above 1. 
The assumption of normality was met, as assessed by P-P Plot.  
The multiple regression model did not predict number of barriers in a statistically 
significant way, F(6, 81) = 0.842, p = .542. R
2
 for the overall model was 5.9% with an 
adjusted R
2
 of -0.10%, a negligible effect size according to Cohen (1988). None of the five 
variables added statistically significantly to the prediction, p > .05. Regression coefficients and 
standard errors can be found in Table 5. Correlation coefficients within the context of the 
regression analysis can be found in Table 6. 
Table 5. Summary of Multiple Regression Analysis: Barriers to Diagnosis (N = 88) 
Variable B  SEB β 
Intercept 1.70 1.19 
Geography -0.08 0.05 -0.18 
Income -0.05 0.10 -0.07 
Ethnicity -0.45 0.43 -0.12 
Education 
ASD-DC Total Score 
1.24 
0.01 
0.11 
0.01 
0.15 
0.02 
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = 
standardized coefficient 
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Table 6.Correlation Coefficients of Multiple Regression Analysis: Barriers to Diagnosis (N = 88) 
Variable r  partial semipartial p 
Geography -0.13 -0.17 -0.17 0.12 
Income -0.01 -0.06 -0.06 -0.55 
Ethnicity -0.09 -0.12 -0.11 0.30 
Education 
ASD-DC Total Score 
0.09 
0.01 
0.13 
0.02 
0.12 
0.02 
0.25 
0.83 
 
Excluding participants outside the ASD-DC range. This analysis excluded individuals whose 
children with ASD were outside of the ASD-DC age range (2-19 years) at the time of survey 
completion. This left a total of 68 participants for the following analysis, which is slightly lower 
than the sample size recommended via a-priori G*Power analysis. All factors were entered into 
the regression simultaneously.  
Overall, caregivers reported experiencing a mean of 1.74 (SD = 1.48) perceived barriers 
to diagnostic services for their child. There was linearity as assessed by partial regression plots 
and a plot of studentized residuals against the predicted values. There was homoscedasticity, as 
assessed by visual inspection of a plot of studentized residuals versus unstandardized predicted 
values. There was no evidence of multicollinearity, as assessed by tolerance values greater than 
0.1. Homoscedasticity was assessed via visual inspection of a plot of studentized residuals versus 
unstandardized predicted values. There was one studentized deleted residuals greater than ±3 
standard deviations for an individual reporting 7 of 10 possible barriers to diagnosis (studentized 
residual = 3.29), but inspection of the data point indicated no probable error in data entry or other 
reason for removal, and leverage value of 0.13 was within the acceptable range so this data point 
was maintained. There was one leverage value greater than 0.2, with a value of 0.24, but 
inspection of Cook’s distance fell within acceptable limits and the data participant was 
maintained. There were no values for Cook's distance above 1. The assumption of normality was 
met, as assessed by P-P Plot.  
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The multiple regression model did not predict number of barriers in a statistically 
significant way, F(5, 61) = 0.97, p = .455.   R
2
 for the overall model was 7.3% with an 
adjusted R
2
 of -0.2%, a small effect size according to Cohen (1988). None of the five variables 
added statistically significantly to the prediction, p > .05. Regression coefficients and standard 
errors can be found in Table 7. Correlation coefficients within the context of the regression 
analysis can be found in Table 8. Of note, examination of correlation tables independent of the 
regression analysis revealed that ethnicity was significantly correlated with the total number of 
barriers to diagnosis (r = -0.2, p = .049).  
Table 7. Summary of Multiple Regression Analysis: Barriers to Diagnosis (N = 68) 
Variable B  SEB β 
Intercept 2.67 1.56 
Geography -0.98 0.07 -0.15 
Income -0.08 0.13 -0.10 
Ethnicity -0.97 0.54 -0.23 
Education 
ASD-DC Total Score 
0.06 
0.00 
0.15 
0.01 
0.06 
-0.02 
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = 
standardized coefficient 
 
Table 8. Correlation Coefficients of Multiple Regression Analysis: Barriers to Diagnosis (N = 
68) 
Variable r  partial semipartial p 
Geography -0.12 -0.15 -0.14 0.25 
Income -0.07 -0.08 -0.08 0.53 
Ethnicity -0.20  -0.22 -0.22 0.08 
Education 
ASD-DC Total 
Score 
0.24 
0.01 
0.05 
-0.02 
0.05 
-0.02 
0.71 
0.86 
 
Predictors of Professional Reassurances as Perceived Barrier to Diagnosis 
Descriptive analyses revealed that 33 (37.50%) of participants reported having received 
reassurances from professionals (e.g., pediatricians) that assessment was not needed at the time 
of parents’ expressed concerns.  Binomial logistic regression was used to investigate factors 
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related to likelihood of encountering these barriers including geography, income, ethnicity, 
education, and ASD symptom severity. 
Linearity of continuous variables with respect to the logit of the dependent variable 
(reporting professional reassurances as a perceived barrier to diagnosis) was assessed using Box-
Tidwell statistic. Bonferroni correction was applied resulting in accepting statistical significance 
of p = .005 (Tabachnick & Fidell, 2007). All continuous variables were found to be linearly 
related to the logit of the dependent variable (practitioner reassurances). No outliers were 
identified. The logistic regression model was not statistically significant, χ2(6) = 3.46, p = .750. 
The model explained 5.3% (Nagelkerke R
2
) of the variance in whether professional reassurances 
were experienced as a barrier and correctly classified 63.6% of cases. None of the predictor 
variables were statistically significant.  Specificity was 94.5% and sensitivity was 12.1%. 
Additional details are presented in Table 9.  As with the regression analysis for total number of 
barriers to diagnosis, the regression was also run excluding those participants who were outside 
of the age range for which the ASD-DC was designed. No significant differences from the below 
results were noted, thus those results are not included here. 
Table 9. Logistic Regression Predicting Professional Reassurances as Barrier to Diagnosis 
 B SE Wald df p Odds  95% CI for Odds Ratio 
      Ratio Lower Upper 
Minority -0.53 0.65 0.68 1 .408 0.59 0.17 2.08 
Education 0.20 0.18 1.27 1 .259 1.22 0.86 1.72 
Geography 
    Geo (1) 
    Geo (2) 
ASD-DC Total 
Income 
 
-0.55 
-0.45 
0.02 
-0.10 
 
0.84 
0.83 
0,02 
0.16 
0.44 
0.44 
0.29 
1.29 
0.31 
2 
1 
1 
1 
1 
.804 
.510 
.590 
.255 
.580 
 
0.11 
0.13 
1.10 
0.92 
 
0.11 
0.13 
0.98 
0.92 
 
2.98 
3.24 
1.05 
1.25 
Constant -1.97 1.85 1.12 1 .289 0.14   
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Ethnic and Familial Barriers to Diagnostic Services 
Fourteen (15.91%) participants encountered disagreement among caregivers or other 
family factors that impacted receiving first diagnosis. Chi-square test was implemented to test for 
association between ethnic status (minority or majority) and likelihood of reporting family 
factors as a barrier to diagnostic services. Due to one expected cell frequency less than 5, 
Fisher’s exact test was interpreted. One of 13 participants who identify as ethnic minorities 
(7.69%) and 13 of 75 self-identified white participants (17.33%) reported family disagreement as 
a barrier to diagnostic service. This did not represent a statistically significant association 
between ethnicity and familial barriers to diagnostic services, χ2(1) = .683, p = .343.  
Perceived Barriers Resulting in Discontinuation of Previous Interventions 
 Of the 88 participants initially retained from analyses, four were excluded from questions 
regarding treatment because they had not yet begun receiving treatment. Additionally, six more 
were excluded because they dropped out of the survey after answering questions about the 
diagnostic process and autism symptom severity. This left 78 participants for the following 
analyses. Of the 78 participants who answered questions about intervention practices, 50 had 
reported discontinuing at least one EBP, 38 had discontinued at least one Emerging treatment, 
and 48 had discontinued at least one Complimentary / Alternative practice. Overall, a total of 48 
participants had discontinued some non-EBP (either Emerging or Complimentary / Alternative 
practice). Additional details regarding discontinued EBPs are presented in Table 10. Details 
regarding discontinued non-EBPs are presented in Table 11.  
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Table 10. Discontinued EBPs (Total N = 78) 
Intervention n Percent 
Evidence-based practice (EBP) 
ABA-Based Behavior Therapy 
Cognitive Behavioral Therapy 
Modeling 
Pivotal Response Training 
EIBI 
Language Production 
Parent Training 
Peer Training 
Visual Schedules 
Scripting 
Self Management Training 
Social Skills Package 
Speech Therapy 
Social Stories 
 
22 
7 
4 
2 
19 
3 
2 
1 
6 
1 
1 
3 
22 
9 
 
28.21 
8.97 
7.84 
2.56 
24.36 
3.85 
2.56 
1.28 
7.69 
1.28 
1.28 
3.85 
28.21 
11.54 
 
Table 11. Discontinued non-EBPs (Total N = 78) 
Intervention n Percent 
Emerging (Non-EBP) 
Functional Communication 
Exercise 
Massage Therapy 
Music Therapy 
Occupational Therapy 
Physical Therapy 
Picture Exchange (PECS) 
Sign Instruction 
Structured Teaching 
Complimentary/Alternative (Non-EBP) 
Acupuncture 
Animal-Based 
Art Therapy 
Sensory Integration 
Osteopathy 
Facilitated Communication 
Floor Time 
Oxytocin 
Play Therapy 
Special Diet 
Vitamins 
Chelation 
Hyperbaric Chamber 
Packing / Holding  
 
3 
3 
2 
8 
16 
7 
3 
3 
1 
 
0 
4 
1 
7 
4 
0 
5 
1 
5 
12 
8 
3 
2 
0 
 
3.85 
3.85 
2.56 
10.26 
21.51 
8.97 
3.85 
3.85 
1.28 
 
0.00 
7.84 
1.28 
8.97 
7.84 
0.00 
6.41 
1.28 
6.41 
15.38 
10.26 
3.85 
2.56 
0.00 
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Caregivers endorsed a variety of reasons for quitting previously tried interventions.  The 
78 participants reporting on intervention history endorsed a range of 0-5 (M = 1.04; SD = 1.22) 
of 10 possible barriers resulting in discontinuation of EBPs. Of the 50 participants who reported 
having discontinued at least one EBP, the most commonly cited reasons for discontinuation were 
changes in eligibility (most commonly cited for EIBI), out of pocket expense, and “other.” The 
“other” category provided an option for caregivers to explain the reasons for discontinuation. 
Write-in answers included a variety of reasons such as moving to a new geographic location, 
changing schools, or caregiver separation/divorce. Of note, analysis excludes those who reported 
in the “other” column that they had discontinued services for a non-barrier related reason (e.g., 
the intervention improved symptoms such that the intervention was no longer needed). Table 12 
provides additional details about reasons for quitting EBPs.  
Table 12. Reasons for quitting past EBPs (N = 78) 
Barrier n Percent 
Not Working 
Expense 
Eligibility (total) 
     Eligibility (excluding EIBI) 
Insurance change 
Scheduling 
Provider relationship 
Did not like in home 
Proximity 
Challenging behaviors 
Other barrier 
8 
14 
18 
7 
2 
4 
7 
1 
2 
2 
13 
10.26 
17.95 
23.08 
8.97 
2.56 
5.13 
8.97 
1.28 
2.56 
2.56 
16.67 
 
Similar to EBPs, the 48 caregivers who reported discontinuation of a non-EBP endorsed a 
variety of reasons for discontinuation. Of the reasons for discontinuing non-EBP interventions, 
most commonly cited were treatment was not working, out of pocket expense too great, and 
“other.” Reasons listed as “other” included child losing interest, providers quitting or moving to 
a different location, or family relocating. The 78 participants reporting on intervention history 
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endorsed a range of 0-6  (M = 1.24; SD = 1.48) of 10 possible perceived barriers resulting in 
discontinuation of non-EBPs. Additional detail is provided in Table 13. 
Table 13. Reasons for Quitting Past Non-EBP (N = 78) 
Barrier n Percent 
Not Working 
Expense 
Eligibility  
Insurance change 
Scheduling 
Provider relationship 
Did not like in home 
Proximity 
Challenging behaviors 
Other 
24 
17 
10 
2 
6 
3 
0 
2 
5 
14 
30.77 
21.79 
12.82 
2.56 
7.69 
3.85 
0.00 
2.56 
6.41 
17.95 
 
Factors Predicting Barriers to EBPs 
Multiple regression was used to investigate factors related to experiencing greater 
numbers of perceived barriers to diagnostic services. Investigated factors included geography 
(living in urban, suburban, or rural areas), family income, ethnicity (minority or not), caregiver 
education level, and ASD-DC Total Score. Because individuals who have experienced a longer 
period of time between diagnosis and present have had greater opportunity to seek, begin, and 
discontinue treatment, this time span was included in the regression as a covariate. Subsequently, 
all variables of predictive interest were entered simultaneously. As previously noted, 20 of the 
ASD-DC scores were for individuals outside of the designed age range (2-16 years). To account 
for this, the analysis was run both with and without these individuals included. Results of both 
analyses are reported below. 
All participants included. For this participant sample of N = 78, linearity was demonstrated by 
partial regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 1.85. The assumption of 
homoscedasticity was met, as assessed by visual inspection of a plot of studentized residuals 
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versus unstandardized predicted values. There was no evidence of multicollinearity, as assessed 
by tolerance values greater than 0.1. Inspection of residuals revealed one studentized deleted 
residual greater than ±3 standard deviations for an individual reporting 5 of 8 possible barriers to 
diagnosis (studentized residual = 3.53), but inspection of the data point indicated no probable 
error in data entry or other reason for removal, and leverage value of 0.08 was within the 
acceptable range so this data point was maintained. In one case, a leverage value greater than 0.2 
was found; levels of 0.2 to 0.5 are considered “risky,” and values of 0.5 are considered 
unacceptable (Cook & Weisberg, 1982; Laerd, 2015). The leverage value of .26 indicated a need 
to look more closely at the possibility of undue influence on results. Inspection of Cook’s 
distance values indicated no values greater than 1 (range was 0.00 to 0.14), thus all participants 
were retained. The assumption of normality was met, as assessed by P-P Plot. The first model, 
accounting for time elapsed since diagnosis, did not predict number of barriers causing 
discontinuation of EBP, R
2 
= 0.02, F(1, 76) = 1.34, p = .251, adjusted R
2
 = 0.004. The addition of 
ethnicity, geography, income, ASD-DC score, and education did not lead to a statistically 
significant increase in R
2
, which increased by 0.06. The full model of time elapsed since 
diagnosis, caregiver education level, autism symptom severity, family income, caregiver 
ethnicity, and geography did not predict number of perceived barriers causing discontinuation of 
EBP in a statistically significant way, R
2 
= 0.07, F(5, 71) = 0.82, p = .478, adjusted R
2
 = -0.01. 
Regression coefficients and standard errors can be found in Table 12 (below). Correlation 
coefficients within the context of the regression analysis can be found in Table 13 (below).  Of 
note, inspection of correlation matrix independent of regression analysis revealed a significant 
correlation between barriers to EBP and income (r = -.21, p = 0.31). Regression coefficients and 
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standard errors can be found in Table 14. Correlation coefficients within the context of the 
regression analysis can be found in Table 15. 
Table 14. Hierarchical Multiple Regression Predicting Number of Barriers Resulting in 
Discontinuation of EBPs (N = 78) 
 Model 1 (Covariate) Model 2 
Variable B SEB β B SEB β 
Constant 
Months since diagnosis 
Geography 
Income 
Ethnicity 
Education 
ASD-DC Total Score 
0.86 
0.01 
 
0.21 
0.01 
 
 
0.13 
0.44 
0.01 
-0.02 
0.12 
-0.22 
0.05 
-0.01 
1.16 
0.01 
0.05 
0.09 
0.40 
0.10 
0.01 
 
0.17 
-0.05 
0.18 
-0.07 
0.06 
-0.03 
R
2
 0.02   0.07   
F 1.34   0.93   
Δ R2 0.02   0.06   
Δ F 1.34   0.52   
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = 
standardized coefficient 
 
Table 15. Correlation Coefficients of Multiple Regression: Barriers to EBPs (N = 78) 
Variable r  partial semipartial p 
Model 1 
     Months since diagnosis 
Model 2 
     Months since diagnosis 
     Geography 
 
0.13 
 
0.13 
0.02 
 
0.13 
 
0.16 
-0.05 
 
0.13 
 
0.15 
-0.05 
 
0.251 
 
0.182 
0.656 
     Income 0.21 0.15 0.15 0.204 
     Ethnicity -0.20 -0.07 -0.06 0.577 
     Education 
     ASD-DC Total Score 
0.15 
-0.03 
0.06 
-0.03 
0.05 
-0.03 
0.639 
0.784 
 
Excluding participants outside the ASD-DC age range. This regression analysis excluded data 
from participants whose children with ASD were outside of the ASD-DC age range (2-16 years) 
at the time of survey completion. This left a total of 60 participants for the following analysis, 
which is slightly lower than the sample size recommended via a-priori G*Power analysis. In 
analyzing that necessary assumptions were met, linearity was present as assessed by partial 
regression plots and a plot of studentized residuals against the predicted values. The assumption 
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of homoscedasticity was met as assessed by visual inspection of a plot of studentized residuals 
versus unstandardized predicted values. There was no evidence of multicollinearity, as all 
tolerance levels were greater than 0.1. There was one studentized deleted residual greater than ±3 
standard deviations for an individual reporting 5 of 8 possible barriers to diagnosis (studentized 
residual = 3.44), but inspection of the data point indicated no probable error in data entry or other 
reason for removal, and leverage value of 0.139 was within the acceptable range so this data 
point was maintained. There were seven instances of leverage values greater than 0.2; as noted 
above, levels of 0.2 to 0.5 are considered “risky” and values of 0.5 are considered unacceptable 
(Cook & Weisberg, 1982; Laerd, 2015). The leverage values ranging from 0.21 to 0.26 indicated 
a need to look more closely at the possibility of undue influence on results using Cook’s 
distance. Inspection of Cook’s distance values indicated no values greater than 1 (range was 0.00 
to 0.22), thus all participants were maintained. The assumption of normality was met, as assessed 
by P-P Plot. The first model, accounting for time elapsed since diagnosis, did not predict number 
of barriers causing discontinuation of EBP, R
2 
= 0.05, F(1, 58) = 2.82, p = .098, adjusted R
2
 = 
0.03. The addition of ethnicity, geography, income, ASD-DC score, and education did not lead to 
a statistically significant increase in R
2
, which increased by 0.123. The full model of time elapsed 
since diagnosis, caregiver education level, autism symptom severity, family income, caregiver 
ethnicity, and geography did not predict number of barriers causing discontinuation of EBP in a 
statistically significant way, R
2 
= 0.17, F (6,53) = 1.79, p = 0.118, adjusted R
2
 = 0.08; however, 
income was significantly correlated with barriers to EBP (r = 0.35, p = .040). Regression 
coefficients and standard errors can be found in Table 16.  Correlation coefficients within the 
context of the regression analysis can be found in Table 17.  
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Table 16. Hierarchical Multiple Regression Predicting Number of Barriers Resulting in 
Discontinuation of EBPs (N = 60) 
 Model 1 (Covariate) Model 2 
Variable B SEB β B SEB β 
Constant 
Months since diagnosis 
Geography 
Income 
Ethnicity 
Education 
ASD-DC Total Score 
 
0.68 
0.01 
 
0.27 
0.01 
 
 
0.22 
0.43 
0.01 
-0.03 
0.25 
-0.10 
-0.02 
-0.01 
1.33 
0.01 
-0.06 
0.12 
0.46 
0.13 
0.01 
 
0.21 
-0.45 
0.34 
-0.03 
-0.03 
-0.08 
R
2
 0.05   0.17   
F 2.82   1.79   
Δ R2 0.05   0.12   
Δ F 2.82   1.56   
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = 
standardized coefficient 
 
Table 17. Correlation Coefficients of Multiple Regression: Barriers to EBPs (N = 60) 
Variable r  partial semipartial p 
Model 1 
     Months since diagnosis 
Model 2 
     Months since diagnosis 
     Geography 
 
0.22 
 
0.22 
-0.02 
 
0.22 
 
0.21 
-0.06 
 
0.22 
 
0.20 
-0.06 
 
0.098 
 
0.120 
-0.660 
     Income 0.35 0.28 0.26 0.040* 
     Ethnicity -0.20  -0.03 -0.03 0.828 
     Education 
     ASD-DC Total Score 
0.18 
0.01 
-0.02 
-0.02 
-0.02 
-0.02 
0.863 
0.564 
 
The direction of the correlation between income and perceived number of treatment 
barriers indicated that higher income was related to increased difficulty maintaining EBP 
services.  As insurance is closely related to the out of pocket costs of treatment, follow-up testing 
was conducted to investigate the relationship between insurance type and number of perceived 
EBP barriers reported.  Due to non-normal distribution of data (thus violating assumptions for 
one-way ANOVA), a Kruskal-Wallis H test was run to determine if there were differences in 
number of barriers reported among three groups based on insurance type: public only, private 
only, or both public and private. Distributions of total number of perceived EBP barriers were 
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not similar for all groups, as assessed by visual inspection of a boxplot. The distributions of 
scores were not statistically significant among groups, χ2(2) = 3.46, p = .178. Participants were 
classified into three groups: private insurance only (n = 29), public insurance only (n = 26), and 
having both private and public insurance (n = 22). Information on number of barriers reported 
per group is presented in Table 18.  
Table 18. Perceived Number Barriers Causing Discontinuation of EBP x Insurance Type   
Group N Mean(SD) Range 
Public Insurance 26 0.69 (0.88) 0-5 
Private Insurance 29 1.28 (1.56) 0-3 
Both Types Insurance 22 1.14 (1.04) 0-3 
SD = Standard Deviation 
 
Predictors of Time Between ASD Diagnosis and First ASD Symptom Treatment 
 Multiple regression was utilized to investigate the relationship between various 
demographic factors of interest (geography, caregiver education, family income, ethnicity, and 
ASD-DC total score) and the time between formal ASD diagnosis and receipt of services 
targeting ASD symptoms. As previously noted, 24 participants reported their child had begun 
receiving treatment for ASD symptoms prior to receiving a formal ASD diagnosis. Additional 
information about the types of treatment or how these individuals came to receive the pre-
diagnostic services is not available. Twelve individuals reported beginning treatment within one 
month of receiving diagnosis. Of those who have experienced a delay between diagnosis and 
treatment, time delay ranged from one month to 31 months. (M = 5.42; SD = 7.36).  
Overall, caregivers reported a mean of -0.51 (SD = 13.83) months from diagnosis to 
treatment, indicating a slight tendency to receive therapeutic services of some type prior to 
receiving formal diagnosis. It is possible that some were enrolled in state-funded early 
intervention programs due to conditions often seen early in development for individuals later 
diagnosed with ASD, including delayed speech or other milestones. Factors investigated 
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included geography (rural, suburban, or urban), child ethnicity, caregiver level of education, 
family income, and ASD symptoms severity as reported via the ASD-DC. As with previous 
regression analyses, multiple regression to investigate these relationships was conducted first 
with all participants and then excluding those participants whose children were outside of the 
ASD-DC age range. Results were not significantly different.  
All Participants Included 
 Four of the 88 participants were excluded from this analysis because they reported their 
children have not yet begun receiving ASD interventions. A total of 84 participants remained for 
this analysis. There was independence of residuals, as assessed by a Durbin-Watson statistic of 
2.1. There was linearity as assessed by partial regression plots and a plot of studentized residuals 
against the predicted values. There was homoscedasticity, as assessed by visual inspection of a 
plot of studentized residuals versus unstandardized predicted values. There was no evidence of 
multicollinearity, as assessed by tolerance values greater than 0.1. Inspection of casewise 
diagnostics revealed two cases with studentized residuals greater than 3 (SR = -8.50 and -4.47, 
respectively). In each of these cases, caregivers reported having accessed treatment for ASD 
symptoms many months prior to receiving a formal ASD diagnosis (112 months and 168 
months, respectively). Further inspection revealed neither of these points had leverage values 
greater than 0.2, nor did they have Cook’s distance values greater than 1. Accordingly, these two 
cases were retained for the following analysis. A cubed root transformation was applied to the 
data due to observed deviations from normality upon inspection of P-P histogram.  
The multiple regression model did not predict time between diagnosis and first treatment 
for ASD symptoms in a statistically significant way, F(5, 78) = 1.55, p = .183. R
2
 for the overall 
model was 9.1% with an adjusted R
2
 of 0.03%, a negligible effect size according to Cohen 
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(1988). Overall, the model did not predict time from diagnosis to treatment in a statistically 
significant way, though ethnicity did contribute significantly to the model (r = .22, p = .046). 
Regression coefficients, correlations, and standard errors can be found in Tables 19 and 20. 
Table 19. Summary of Multiple Regression Analysis: Diagnosis to Treatment Time (N = 84) 
Variable B  SEB β 
Intercept -1.20 1.72 
Geography 0.01 0.07 0.01 
Income 0.27 0.14 0.25 
Ethnicity 1.26 0.62 0.23 
Education 
ASD-DC Total Score 
-0.15 
0.01 
0.16 
0.01 
-0.13 
0.05 
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = 
standardized coefficient 
 
Table 20. Correlation Coefficients of Multiple Regression: Diagnosis to Treatment Time (N = 
84) 
Variable r  partial semipartial p 
Geography -0.05 -0.01 0.01 0.962 
Income 0.16 0.21 0.21 0.065 
Ethnicity 0.22  0.22 0.22 0.046* 
Education 
ASD-DC Total 
Score 
-0.12 
-0.03 
-0.11 
-0.03 
-0.11 
-0.05 
0.337 
0.649 
 
Excluding Participants Outside the ASD-DC Age Range 
Sixty-three participants remained after excluding those whose children were outside of 
the ASD-DC age range at time of survey completion. Of note this is slightly below the sample 
size recommended by G*Power (Faul, Erdfelder, Lang, & Buchner, 2007)). There was linearity 
as assessed by partial regression plots and a plot of studentized residuals against the predicted 
values. There was homoscedasticity, as assessed by visual inspection of a plot of studentized 
residuals versus unstandardized predicted values. There was no evidence of multicollinearity, as 
assessed by tolerance values greater than 0.1. Inspection of casewise diagnostics revealed no 
problematic outliers. Leverage values and Cook’s distance were all within acceptable limits. The 
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cubed root transformation used in the previous analysis was similarly applied to this analysis due 
to observed deviations from normality upon inspection of P-P histogram.  
The multiple regression model did not predict time between diagnosis and first treatment 
for ASD symptoms in a statistically significant way, F(5, 57) = 0.96, p = .449. R
2
 for the overall 
model was 7.8% with an adjusted R
2
 of -0.01%, a negligible effect size according to Cohen 
(1988). Overall, the model did not predict time from diagnosis to treatment in a statistically 
significant way, all predictor variables p > .05 Regression coefficients, correlations, and standard 
errors can be found in Tables 21 and 22 (below). 
Table 21. Summary of Multiple Regression Analysis: Diagnosis to Treatment Time (N = 63) 
Variable B  SEB β 
Intercept -0.01 1.81 
Geography -0.28 0.08 -0.05 
Income 0.10 0.16 0.10 
Ethnicity 1.17 0.66 0.24 
Education 
ASD-DC Total Score 
-0.01 
-0.01 
0.19 
0.02 
-0.01 
-0.02 
Note: B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = 
standardized coefficient 
 
Table 22. Correlation Coefficients of Multiple Regression: Diagnosis to Treatment Time (N = 
63) 
Variable r  partial semipartial p 
Geography -0.10 -0.05 -0.04 .728 
Income 0.08 0.08 0.08 .542 
Ethnicity 0.26  0.23 0.23 .080 
Education 
ASD-DC Total 
Score 
0.00 
-.11 
-0.01 
-0.02 
-0.01 
-0.22 
.947 
.862 
 
Currently Desired Interventions 
 Participants were asked about treatments that they would like to try in the future. A total 
of 51 participants stated they were seeking additional services. Of those, 41 of the answers could 
be clearly categorized into EBP or non-EBP interventions. Twenty-seven desired EBPs; 14 
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desired non-EBP interventions. Twenty-one participants indicated they were not interested in 
additional services at this time and were thus excluded from these analyses.  
Descriptive Analysis 
Interventions most frequently desired were related to ABA-based therapy (n = 11), social 
skills (n = 8), services from a psychologist specially trained in ASD and/or CBT (n = 5), and 
speech therapy (n = 5). A wide variety of both EBPs and non-EBPs were desired, including 
hippotherapy (horseback riding used as a therapeutic intervention), off-label medication, help 
with transitioning to adulthood or learning job skills, peer modeling, floor time, sensory 
integration therapy, art or music therapy, dietary changes, pivotal response training, massage, 
acupuncture, osteopathy, academic tutoring, and programs that incorporated typically developing 
peers.   
The most frequently cited barriers to desired future interventions were expense, 
scheduling / time required, and “other,” closely followed by waitlist and proximity (too far) or 
other transportation issues.  Of caregivers seeking additional interventions, a range of 1-5 
barriers (M = 2.02; SD = 1.17) was reported. Participants were also asked to rank the perceived 
barriers in order of difficulty each posed, with 1 indicating “most problematic.” Information 
about perceived barriers to the desired services is provided in Table 23.  
Table 23.  Perceived Barriers to Desired Interventions (N = 51) 
Barrier N (%) Ranked #1  (N%)  
Cost 
Scheduling or time required 
Other 
Proximity or transport 
Wait list 
Process to access 
Problem Behaviors 
26 (50.98) 
18 (35.29) 
17 (33.33) 
15 (29.41) 
15 (29.41) 
10 (19.61) 
5 (9.80) 
15 (29.41) 
5 (9.80) 
10 (19.61) 
8 (15.68) 
5 (9.80) 
3 (5.89) 
2 (3.92) 
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 Regarding the rank of how problematic the above barriers were perceived, cost was 
perceived as the number one barrier for 15 of the participants (29.41%). Ten participants 
(19.61%) perceived “other” barriers as most problematic based on rank ordering, and 
distance/transportation was most problematic for 8 participants (15.69%). The “other” responses 
of some caregivers indicated significant frustration. For example, responses included “Have you 
ever tried to get the school to provide something?!” and “So many treatments without proof- so 
much Snake Oil. Where to turn?” 
Predictors of Desiring EBP Over Non-EBP 
A binomial regression was utilized to inspect factors related to whether a participant who 
desired additional services was seeking EBP vs non-EBP treatments. Of the 51 participants who 
indicated a desire for additional services, 41 answers were able to be categorized into EBP (n = 
27) or non-EBP (n = 14) approaches. (The remaining 10 responses were not evident, and 
included comments such as “more of what she’s already getting” or “tutoring by someone trained 
in ASD”). Due to smaller sample size (Laerd, 2015a), predictive variables were limited to 
education, income, and ethnicity. Income and ethnicity were chosen due to evidence of 
correlation with past treatment experience in previous analyses; education level was retained 
based on previous studies indicating that parental education affected treatment choices, with 
higher education corresponding with increased used of non-EBPs (e.g., Salomone and 
colleagues, 2015).   
Linearity of the continuous variables with respect to the logit of the dependent variable 
was assessed via the Box-Tidwell (1962) procedure. A Bonferroni correction was applied using 
all eight terms in the model resulting in statistical significance being accepted when p < .00625 
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(Tabachnick & Fidell, 2007). Based on this assessment, all continuous independent variables 
were linearly related to the logit of the dependent variable. There were no observed outliers. 
A binomial logistic regression was performed to ascertain the effects of years of 
caregiver education, income, and ethnicity on the likelihood that they were seeking additional 
EBP rather than non-EBP. The logistic regression model was not statistically significant, χ2(3) = 
9.512, p = .301. The model explained 2.6% (Nagelkerke R
2
) of the variance in treatment choice 
and correctly classified 65.9% of cases. None of the predictor variables were statistically 
significant.  Additional details are presented in Table 24.  
Table 24. Logistic Regression Predicting Likelihood of Seeking EBP at Present Based on 
Minority Status, Education, and Income 
 B SE Wald df p Odds  95% CI for Odds Ratio 
          Ratio Lower Upper 
Minority -0.75 0.90 0.71 1 .401 0.47 0.08 2.27 
Education -0.02 0.24 0.01 1 .983 0.98 0.62 1.56 
Income -0.01 0.20 0.00 1 .995 1.0 0.67 1.46 
Constant 1.376 1.58 0.76 1 .617 3.96   
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CHAPTER 10: DISCUSSION  
Limitations 
There are a few notable limitations to this study. Non-Latino white individuals and 
higher-SES individuals were over-represented in this sample compared to the United States 
averages. Caregivers were self-identified and self-reported their child’s ASD diagnosis; 
diagnoses were not independently verified.  A larger and more demographically representative 
sample would have been desirable. There was a 42% dropout rate for the survey. Nonetheless, 
the dropout rate is in line with other online surveys of similar length without compensation 
(Galesic, 2006). Additionally, results of this study are in line with previous research indicating 
families experience a wide range of barrier types, and some groups (e.g., minority ethnic groups) 
are more likely to experience multiple barriers. 
Descriptive Analyses 
Overall, the study sample accurately represented the higher prevalence of ASD in males 
than females. It has been estimated that ASD occurs approximately 4:1 male to female ratio 
(Bertaglio & Hendren, 2009); in this sample, 77% male and 23% female distribution closely 
mirrors what we would expect in the general population. The sample was not so closely 
representative of the United States’ ethnic makeup. In the 2010 United States Census, 
approximately 33% of the U.S. population reported their ethnicity as something other than non-
Latino white alone, thus qualifying as being of minority ethnic identification (United States 
Census Bureau, 2010a). In this sample, minorities were slightly under-represented. Based on the 
US Census data, a representative sample would be comprised of approximately 66% white, non-
Latino caregivers, but in actuality the sample included approximately 85% white, non-Latino 
caregivers. There were slightly fewer white children with ASD (79.5%). For the purpose of 
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analysis, ethnicity of the caregiver was used, as this was a study of the caregivers’ experiences. 
Families on the higher end of the SES spectrum were also over-represented with a full 34% of 
the sample having achieved at least some graduate school education. Only 8% of the sample had 
no more education beyond high school. Given a roughly 20% high school dropout rate in this 
country (some of whom later go on to receive General Education Development / GED degrees; 
Stetser & Stillwell, 2014), a representative sample would include more individuals with high 
school or less education than the achieved sample. Although the education and income variables 
were not overly correlated, families with higher income were also over-represented. In 2014, the 
median household income in the United States was $53,657 (DeNavas-Walt & Proctor, 2015); in 
this study sample, only 36% reported family incomes of $55,000 or less. The over-representation 
of highly educated, financially well-resourced families may be related to the study being shared 
on a listserv for medical doctors who have children with special needs.  The rural population was 
also somewhat underrepresented. According to the 2010 United States Census (United States 
Census Bureau, 2010b), 19.3% of the population resides in rural areas; in this sample, 9.09% 
reported living in a rural area. 
In this sample, the range of age at first diagnosis varied widely; some variation is 
expected as there were several children with reported diagnosis of Asperger’s Disorder, which 
under the DSM-IV-TR was often not diagnosed until school age (CDC, 2012). The mean age of 
diagnosis was 4.7 years (SD = 3.87 years). In general, recent studies of age at diagnosis have 
found that although ASD can sometimes be reliably diagnosed at age 2 years or younger 
(Council on Children with Disabilities, 2006; Kim & Lord, 2012), the median age is somewhere 
from 4-6 years depending on symptom severity (CDC, 2012; Chakrabarti, 2009; Shattuck et al., 
2009, Yeargin-Allsopp et al., 2003). The children in this sample may have been diagnosed 
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slightly earlier on average than expected, but the widely varying ages are representative of the 
wide ranges reported in the aforementioned studies.  
Fifty-four of the participants in this study reported a gap between diagnosis and 
treatment. Of those individuals who did experience a gap from diagnosis to treatment, the mean 
wait time was 5.42 months (SD = 7.36 months).  The fact that 24 caregivers reported their child 
began receiving services for ASD symptoms prior to receipt of a formal diagnosis was 
unexpected. It is possible that these children benefitted from state-wide early intervention 
services. While each state has their own early intervention program for infants and toddlers with 
disabilities through the Grants for Infants and Families Program Part C (United States 
Department of Education, 2016), different states may have different criteria for receiving 
services. Children generally qualify for services by scoring below a certain cutoff on one or more 
developmental domains during standardized testing of abilities after referral for evaluation from 
a healthcare provider or family member (the cutoff scores or number of domains that must be 
lower than expected may vary from state to state). As discussed under the Diagnosis section of 
this paper, developmental delays are often evident in children with ASD before they receive an 
ASD diagnosis, and thus these children may qualify for services (e.g., speech therapy) prior to a 
formal ASD diagnosis. 
Perceived Barriers to Diagnostic Services 
The majority of participants (n = 75; 85.23%) reported at least one barrier to diagnostic 
services, with the majority reporting multiple barriers (M = 1.68; SD = 1.38). Most frequently 
reported were long wait lists, reassurances from professional providers, and difficulties with 
scheduling (e.g., having to balance work schedules with clinic visits, or juggling other family 
responsibilities). The high number (n = 19; 21.59%) who experienced problems with scheduling 
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suggests that professionals may consider offering occasional scheduling outside of the typical 
9am-5pm workday to accommodate families who have difficulty scheduling. For example, 
occasional evening or weekend hours may alleviate some of the difficulty caregivers face in 
scheduling diagnostic services. Anecdotally per the authors’ experience, difficulty with childcare 
for other children also presents a difficulty; for example, if a parent has another child with 
special needs, or has to travel to a clinic, stay on campus during the assessment period, and then 
drive back home, the parent may not be able to pick up other children from school or aftercare 
programs on time. Flexible scheduling or assisting with figuring out childcare for other children 
may be approaches clinicians can take to assist families facing these scheduling difficulties.  
Regarding perceived barriers to diagnosis, the author was especially interested in those 
factors that might be ameliorated with educational efforts. Specifically, the author was interested 
in factors affecting likelihood of experiencing reassurances from professionals or disagreement 
among primary caregivers as perceived barriers to diagnostic services. While the most common 
barrier was long wait lists (reported by 49 participants at a rate of 55.68% of the sample), 
inspection of the most frequently reported perceived barriers to diagnostic services revealed a 
surprising number (33, representing 37.5% of the sample) reported reassurances from 
professionals as a factor delaying diagnosis. It is perhaps important to note that this represents 
perceived reassurances against diagnostic services; it is possible that healthcare professionals did 
not intend to send this message. It is also possible that caregivers are counting non-healthcare 
professionals in this category since they were not asked to specify from whom they received this 
message, although the examples provided in the survey were all healthcare professionals. 
Qualitative data (where participants were given the option to type in additional responses) 
indicates that ASD symptoms presented in the context of other developmental problems (e.g., 
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Down Syndrome, partial agenesis of the corpus callosum, global developmental delay) may have 
been attributed to the comorbid disorders despite parental concerns that “something else” was 
going on. For example, one respondent answered “Pediatrician thought symptoms were due to 
Down Syndrome.” Similarly, a second respondent stated of their child with partial agenesis of 
the corpus callosum that “we were told that because of [her condition] she could not have autism. 
We fought for years before someone would finally do research and discovered she can have 
both.” Another respondent replied, “We were told the answers to an 8 question screening 
indicated possible autism. We were surprised when the doctor suggested that we might want to 
change some of our answers. We didn’t change our answers, but it did make us concerned about 
our child’s doctor.” Presumably, these parents were able to get a referral for diagnostic services 
that ultimately validated their concerns. It was hypothesized that a binomial regression to inspect 
factors predicting this experience would show that an increase in ASD symptom severity (as 
measured by the ASD-DC) would correspond with a decreased likelihood of perceiving 
professional reassurances as a barrier to diagnosis. It was also hypothesized that increased 
education of parents would also correspond with a decrease in perceiving this barrier, as more 
educated parents may be better able to engage in good-quality research prior to appointments and 
thus may be able to speak more precisely about their child’s symptoms and ask more pointed 
questions about autism-specific concerns. However, while ASD-DC total score and caregiver 
educational attainment were closer to statistical significance than the other variables (at p = 2.89 
and p = .259 respectively), these values are still far from statistical or clinical significance. In the 
context of the available information, there were no statistically significant predictors of 
perceiving professional reassurances as a barrier to diagnostic services.  
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On at least two occasions, parental stressors or comorbidities interfered with pursuit of 
diagnostic services. One participant who reported lack of insurance as a barrier added “in 
fairness, I did not attempt to get insurance coverage… I have ADHD, I was exhausted and 
disorganized.” Another participant (who was not a biological parent) reported that the child’s 
parents were too wrapped up in drug addiction to pursue appropriate medical care at the time 
despite concerns from others. Regarding familial factors, the author was more specifically 
interested in disagreement among caregivers about whether or not to pursue diagnostic services 
as a perceived barrier. With 14 (15.91%) of the participants reporting this as a barrier, family 
disagreement was the 4
th
 most common barrier reported, after waitlist (55.68%), professional 
reassurances (37.50%), and cost (17.05%). Based on literature review  (see the section on 
Community and Cultural factors) revealing widely varying cultural beliefs about autism causes 
and the stigma associated with the disorder, it was hypothesized that ethnicity would impact 
likelihood of perceiving caregiver disagreement as a barrier. In actuality, results of the chi-square 
test did not indicate a statistically significant increase in experiencing this barrier for participants 
who identify as ethnic minorities. This result should be interpreted cautiously, as non-white 
participants were under-represented in this sample, and relatively few (15.91%) endorsed this 
barrier. Additional research into this topic would benefit from larger sample sizes that contain a 
greater number of individuals endorsing this perceived barrier.  
The author was also interested in factors that predict greater likelihood of experiencing 
multiple barriers to diagnosis. Multiple regression was used to investigate ethnicity, geographical 
location, household income, caregiver educational attainment, and ASD symptom severity based 
on ASD-DC Total Score as predictive factors for experiencing increased numbers of perceived 
barriers. It was hypothesized that living in an urban area, higher household income, higher 
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educational attainment, and greater ASD symptom severity would be correlated with fewer 
reported barriers to diagnostic services, whereas identifying as an ethnic minority would be 
correlated with an increase in barriers, perhaps in part due to a correlation in this country 
between minority status and greater barriers to achieving higher education and income. In this 
sample, ethnicity was not overly correlated with any of the predictive variables, thus avoiding the 
problem multicollinearity in the analysis. The analysis was run both with and without the 
individuals who were technically outside of the age range for which the ASD-DC was designed. 
Overall, the model did not show statistical significance in predicting the number of barriers 
experienced in pursuit of diagnostic services in either case. Interestingly, in the smaller sample 
that excluded those outside the ASD-DC age range, ethnicity was significantly correlated with 
the outcome variable (number of perceived barriers reported) independent of the model. One 
must be cautious of reading too much into this result as the descriptive correlations provided do 
not account for multiple comparisons in the same way that running the full analysis does, and 
minorities were somewhat under-represented in this sample as previously discussed. However, 
this area may be worthy of additional research in the future with a larger sample size in which 
individuals who identify as ethnic minorities are better represented.  
Perceived Barriers Causing Discontinuation of Past Interventions 
 Descriptive analyses of information related to discontinued past interventions revealed 
that the most frequently discontinued EBPs were ABA-based behavior therapy and speech 
therapy (n = 22; 28.21% for each), followed by EIBI (n = 19; 24.36%). Of note, 11 of the 
individuals who quit EIBI reported the service was discontinued due to changes in eligibility; 
this is unsurprising as many of the state-funded early intervention programs or other 
regional/local programs that help fund EIBI have age cutoffs of 3 or 5 years (and indeed, the 
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very title Early Intensive Behavior Intervention indicates it is a treatment for use during early 
childhood). Due to the way the survey was streamlined based on feedback from dissertation 
committees and pilot participants, it is impossible to determine what was the most common 
cause for discontinuation of ABA-based therapy. It is surprising that only 2 participants (2.56%) 
endorsed distance/proximity to treatment as a major barrier leading to discontinuation of past 
EBP interventions; it may be that individuals take this into account before beginning treatments 
and are unlikely to begin interventions at all if they perceive distance as too great. On the other 
hand, perhaps EBP service provision is improving in less populated areas. On the whole, the 
most frequently reported reasons for discontinuing EBPs were eligibility, expense, and “other.” 
Excluding EIBI, top-ranked reasons for quitting EBPs were expense, “other,” and “not working.” 
The “other” category offered the option for caregivers to elaborate on their answers, and several 
indicated frustration with quality of services provided. For example, one individual stated “the 
county-sponsored stuff was nearly worthless… and private stuff was hugely expensive.” Another 
stated “services were poor quality.”  Other barriers reported in the “other” category included 
“facility closed,” “only helpful if it’s a whole bunch of it, but nobody here provides that,” 
“therapists all geared towards younger patients,” “therapist took a break,” “therapist left now we 
are back on a wait list,” and “unable to find new service providers when old ones quit.” Seven 
individuals (8.97%) reported having discontinued an EBP due to poor relationship with the 
provider, and one due to disliking having services provided in the home.  It is discouraging that 
many individuals discontinued EBPs due to difficulties with provider relationships or due to 
discontinuation of services due to therapists leaving or facilities closing. Certainly, service 
providers should engage in internal quality assessment to ascertain the fidelity of the provided 
services; an EBP is no longer evidence-based if it is not accurately administered. Service 
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providers should also work to ameliorate any difficulties that may arise in the relationship with 
the caregivers when possible. It may be that the caregivers who discontinued due to problems 
with providers never raised their concerns to the providers, thus providers may not have had an 
opportunity to work to rectify the problems. Periodically checking in regarding caregiver 
satisfaction with services provided may be a way to address this concern without taking much 
time, as in periodically asking parents to complete a brief satisfaction questionnaire. It is 
encouraging that far fewer individuals discontinued EBP due to the practice not working (n = 8; 
10.26%) compared to the 24 participants (30.77%) who discontinued non-EBPs for the same 
reason.  Overall, it was hypothesized that cost would be more frequently reported as a barrier to 
non-EBP over EBP because insurance is far more likely to reimburse for EBP. While the 
hypothesized result was true with 17.95% reporting cost as a barrier to EBP and 21.79% 
reporting cost as a barrier to non-EBP, overall out-of-pocket cost was one of the top barriers for 
both types of interventions. 
The most frequently discontinued non-EBPs included occupational therapy (n = 16; 
21.51%), special diets such as gluten or casein-free (n = 12; 15.38%), vitamins (n = 8; 10.26%), 
and sensory integration therapy (n = 7, 8.97%). The top reported reasons for quitting non-EBPs 
included “not working,” expense (n = 17; 21.79%), and “other” (n = 14; 17.95%). As with EBPs, 
a variety of reasons for discontinuation were reported in the “other” category. Examples include 
death of providing practitioner, “therapist had no clue,” “therapy became unavailable,” and 
“therapist feeling he didn’t respond.” Of note, three participants endorsed having used chelation 
therapy and two reported having used hyperbaric chamber therapy in an attempt to treat ASD 
symptoms (one participant endorsed both). It is unsurprising that three of the four participants 
who had tried one of these interventions reported discontinuation because the practices were not 
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working. (The participant who tried both was apparently undeterred by inefficacy, but 
discontinued due to out of pocket cost being too expensive). There is not only substantial 
research to support the ineffectiveness of these approaches, but also that these practices present 
considerable risk of substantial harm. It is on the one hand fortunate that only four participants 
(5.13%) of the 78 in this analysis endorsed having tried these dangerous and sometimes invasive 
techniques; on the other hand, it is troubling that any health care provider would provide these 
interventions without clear medical indication. The author wonders where participants 
encountered spurious claims of efficacy for these dangerous practices; despite the comparatively 
low number of caregivers pursuing hyperbaric chamber or chelation therapies, future research 
into which caregivers are likely to pursue dangerous and invasive practices and where they are 
getting information and treatment could help inform targeted educational efforts to decrease use 
of these ineffective practices in efforts to treat ASD symptoms. 
Given that EBPs for ASD are by definition generally effective at improving ASD 
symptoms, the author was especially interested in factors predicting experiencing a greater 
number of barriers leading to discontinuation of EBPs. Similar to hypothesized results for 
barriers to diagnosis, it was hypothesized that lower household income would predict higher 
numbers of reported barriers. Financial providers in families with lower income may have low-
paying entry-level jobs; many of these jobs entail hourly wages rather than salary. This can make 
it more difficult to take time away from work as any time away entails loss of income. Low-
income families may be more likely to be headed by a single parent, amplifying problems with 
scheduling or transportation. It was also hypothesized that rural location would be indicative of 
higher number of reported barriers, followed by lower educational attainment as a predictor of 
greater perceived barriers. It was hypothesized that higher ASD symptom severity as measured 
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by the ASD-DC would be predict fewer barriers as it may be easier to qualify for multiple 
services or more comprehensive programs, including programs to provide financial assistance for 
healthcare services, when symptoms are more severely impacting functioning. After co-varying 
time elapsed since diagnosis, multiple regression investigating geography, family income, 
ethnicity, caregiver education level, and ASD-DC total scores as predictors revealed the model 
was not effective at predicting increased number of reported barriers to past EBP. As with the 
analysis on barriers to diagnostic services, the analysis was run both with and without the 
participants who were outside of the age range for which the ASD-DC was designed. The results 
were slightly different; in the all-inclusive analysis, income was found to be significantly 
correlated with the outcome variable (number of perceived barriers to EBP reported) but it was 
not significantly predictive within the context of the model. In the analysis that excluded the 18 
participants outside of the ASD-DC age range, income was significantly correlated with higher 
rates of reported EBP barriers. In summary, while the models did not significantly predict 
number of barriers experienced in continuing EBPs, a surprising trend indicated that families 
with higher incomes are more likely to report multiple barriers resulting in discontinuation of 
services.  
In light of the surprising trend that participants from higher-income families were more 
likely to report multiple barriers resulting in discontinuation of EBPs, it was then hypothesized 
that insurance may play a role in this finding, with those with public insurance facing fewer 
challenges to maintaining services. Thomas and colleagues (2007) found that children covered 
by public insurance had much greater odds of using a variety of therapeutic services as well as 
medication management than those covered by private insurance; children covered by public 
insurance were also less likely to use some complimentary/alternative approaches (e.g., 
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supplements) compared to those covered only by public insurance. These same authors also 
found that children without insurance were most likely to receive services that facilitated entry 
into the healthcare system. In 2014, Parish and colleagues found that after controlling for 
symptom severity and demographic characteristics, families with private insurance were more 
than five times as likely to have out of pocket costs for ASD treatments compared to those 
children covered by public health insurance. Most frequently, these costs were related to 
outpatient services, medications, and dental care. The results found in this study may be because 
children from families with lower income are more likely to be covered by Medicaid, which may 
cover more ASD treatment services than the average private insurance plan. Accordingly, 
families who do not qualify for Medicaid due to higher family income may incur significantly 
greater financial burdens for their child’s ASD-related healthcare. Additionally, it is possible that 
these middle- or higher-income families would benefit from some of the services (e.g., 
transportation to and from therapy or medical appointments) that are available to individuals who 
receive Medicaid.   
Inspection of means and standard deviations of number of barriers resulting in 
discontinuation of EBPs indicated that on average, individuals with private insurance reported 
greater difficulty maintaining EBPs than those with public insurance, which is in line with 
previous research. Additionally, individuals who had both public and private insurance reported 
more barriers than those with public only, but fewer than those with private only. The results of 
the Kruskal-Wallis analysis were not significant; however, it is possible that in this sample there 
was a “basement effect” since many individuals (fortunately) reported relatively few barriers to 
EBP. It is possible that more nuanced information regarding insurance type and access to 
services might shed light on the validity of this trend and reveal significant results consistent 
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with results of previously published studies. It is possible that individuals who have both public 
and private insurance experience significantly more frustration in accessing services due to 
difficulties inherent in having both public and private insurance. In particular, public insurance 
(e.g., Medicare) often requires that individuals who have both types of insurance file with their 
primary (private) insurance first. However, the private insurance may not cover the desired ASD 
treatment. Attempts to resolve this issue and obtain coverage can require appeals and multiple 
communications between each insurance provider; even once the process is resolved and public 
insurance agrees to cover what the primary/private insurance does not, periodic reauthorization 
may be required. As laws surrounding ASD coverage by private insurance continue to change 
and more states mandate coverage of at least some EBPs for ASD, continued research into the 
effects of insurance coverage on access to services will remain an important area of research.  
Predictors of Time Between ASD Diagnosis and First ASD Symptom Treatment 
 Overall, caregivers reported a slight tendency for their children to begin receiving 
treatment prior to receiving formal ASD diagnosis (M = 0.51 months prior to diagnosis; SD = 
13.83 months). Particularly in light of the mean age of first diagnosis (M  = 4.70 years, SD = 
3.87 years), the large standard deviation of time between diagnosis and treatment fits with the 
hypothesis that many individuals may have been enrolled in early intervention programs for 
children with developmental delays. Unfortunately the contents of the survey do not allow for 
verification of this hypothesis. If, however, state early intervention programs are identifying 
children at risk for a later diagnosis of ASD, the children would likely be receiving interventions 
targeting communication, a core ASD symptom that is often evident early in development. 
Engagement with early intervention programs would also be likely to facilitate later diagnostic 
assessment for ASD. The large standard deviation also indicates that a considerable number of 
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children experienced a substantial lag between diagnosis and treatment. Results of the regression 
model did not predict time between treatment and diagnosis in a statistically significant way. 
However, ethnicity was significantly correlated with time between diagnostic and treatment 
services; minority caregivers were more likely to report a lag time between diagnosis and 
treatment. This is consistent with previous research; for example, Rosenberg and colleagues 
(2008) found that black children were only half as likely as their white peers to receive early 
intervention services. Zuckerman and colleagues (2014) found that some Latina mothers reported 
avoided seeking out treatment services directly following an ASD diagnosis because the 
diagnosis was so stressful that families needed time to adjust and cope with the news before 
moving on in the process of accessing treatment. Disparities in service access and utilization 
indicate a continued need to develop public policies and culturally-sensitive educational and 
outreach programs to address the gap in service use. 
Currently Desired Interventions 
Fortunately, the majority of caregivers seeking additional ASD interventions for their 
children were seeking EBPs. Similar to the reported barriers to diagnosis and previously tried 
intervention services, cost presented the most frequently cited barrier for desired future 
treatments, and was also the most frequently mentioned as “most problematic or challenging” 
barrier. This is in line with results from the previous analysis regarding barriers to diagnostic and 
previous treatment services. Scheduling or time required was second most frequently ranked, 
though “other” barriers were viewed as slightly more problematic. Regarding scheduling, clinic-
based providers able to offer evening or weekend hours or a combination of clinic and in-home 
services might be well-suited to help address the scheduling difficulties many families face.  
“Other” barriers were the third most frequently and second most highly ranked. “Other” barriers 
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were highly variable, and included desiring services not provided by the child’s assigned school 
system, ineligibility due to age, difficulty getting insurance approval, not knowing where to find 
the services or difficulty locating providers, and comorbid medical diagnoses requiring 
specialized health care. The wide range of difficulties faced in accessing ASD services highlights 
the need for individualized care and, in some cases, assistance with care coordination to help 
connect families with other service providers.  
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CHAPTER 11: CONCLUSION  
ASD is a lifelong neurodevelopmental disorder, but early and accurate diagnosis paired 
with developmentally appropriate interventions across the lifespan can significantly improve 
long-term outcome and quality of life for individuals with ASD and their families. Many of the 
families in this study reported having received some services for ASD symptoms. It is not known 
how many of these children were getting services specifically through state-wide early 
intervention programs for children with developmental delays, but but it is promising that these 
individuals became involved so early on with some type of service provision. It is likely that 
being involved with early intervention services makes it easier to follow up and get in touch with 
the appropriate diagnostic and additional services as ASD symptoms become more apparent or 
problematic as a child ages.  Scheduling diagnostic services can be challenging. More than half 
of caregivers cited long wait lists as a barrier to diagnostic services, and accessing diagnostic 
services can be further complicated by difficulties with scheduling around work, childcare, and 
other obligations. Service providers may consider offering occasional scheduling outside of the 
typical 9am-5pm workday to accommodate families who have difficulty scheduling during these 
times. For example, periodic weekend or evening hours may alleviate some of the difficulty 
caregivers face in scheduling diagnostic services.  
It was surprising how many caregivers (37.5%) reported having been told by 
professionals (e.g., pediatricians) “not to worry” about their child’s difficulties. Caregivers 
reported being reassured that their child would grow out of their problems, felt their concerns 
were dismissed, or were told that their child could not have autism (e.g., due to presence of 
another condition, such as Down Syndrome) and so pursuing diagnostic services was not needed. 
Granted, these were perceived reassurances and it is possible that the message the caregivers 
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heard was not the intended message on the part of the provider; regardless, these high rates of 
misguided professional reassurances perceived as barriers to diagnostic services is disturbing and 
more research into this area is warranted to discover whether additional education of healthcare 
providers on ASD, consideration of more effective communication techniques with parents, or 
both would be beneficial in reducing these rates.  
Although sample size and low rates of caregivers identifying as ethnic minorities is a 
limitation of this study sample, ethnicity was positively correlated with number of perceived 
barriers to diagnosis. Minority caregivers were also more likely to report a lag time between 
diagnosis and treatment.  Despite substantial strides in addressing ethnic disparities in healthcare 
over the past couple of decades, differences still persist. Disparities in services access and 
utilization indicate a continued need to develop public policies and culturally-sensitive 
educational and outreach programs to address gaps in service use. 
The results of this study also highlight the variety of barriers caregivers may face when 
pursuing therapeutic services for their child with ASD. In particular, out of pocket expense 
remains the most often-reported barrier to accessing and maintaining evidence-based 
interventions to treat ASD. Interestingly, those with higher income reported greater number of 
barriers to EBPs. This may be in part related to likelihood of higher income families having 
private, rather than public, insurance. Insurance type appears to be related to number of 
difficulties experienced in treatment and future research in this area is warranted as insurance 
policies continue to change their coverage for ASD-related services. In this study, although 
statistical significance was not reached, the trend was in line with previous research indicating 
that individuals with private insurance tended to report greater difficulties in accessing services 
than those with public insurance. Interestingly, those with both public and private insurance fell 
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in the middle with regard to number of barriers to evidence based treatments. It is possible that 
those who have both types of insurance experience significantly more frustration in accessing 
services due to the process of being told to file first with private insurance, even if that insurance 
does not cover the service, before applying to Medicaid, and then having to content with periodic 
appeals and re-authorization. Each additional required step represents another chance for clients 
to fall through the cracks. Additional research into factors related to insurance-related difficulties 
is warranted.   
Many caregivers reported having discontinued previous EBPs due to difficulties in their 
relationship with the provider or the way in which services were rendered. Based on these 
results, perhaps service providers should more strongly consider engaging in systematic internal 
quality assessment to ascertain the fidelity of the provided services as well as periodically 
checking in regarding caregiver satisfaction with the provided services. For example, providers 
may consider periodically asking parents to complete a brief satisfaction questionnaire as a way 
to scan for areas of dissatisfaction without taking too much time away from clinical services. 
Others discontinued because their therapist left or facility closed, which leads one to wonder 
what factors prohibited these individuals from continuing the same services with a different 
provider.  
 It was encouraging that only a small number (4 total) in the sample endorsed having tried 
any invasive, dangerous non-EBPs in the past. Three of these quit due to the treatments not 
working; one discontinued due to expense. On the other hand, it is disturbing that these 
participants were able to access chelation and hyperbaric chamber treatments for their children 
with no medical indication. Not only are these practices expensive and ineffective at treating 
ASD symptoms, but they also carry risk of significant harm. Continuing research into what leads  
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caregivers to pursue these treatments and what types of providers are providing these potentially 
detrimental services is warranted.  
While significant strides have been made in recent years towards improving timely and 
affordable access to high quality, evidence-based diagnostic and treatment services, many 
caregivers still experience considerable challenges and frustrations when seeking services for 
their children. Clinicians, researchers, and public policy advocates should continue to bear these 
differences in mind as efforts continue to eliminate disparities in access to care.  
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APPENDIX A: SURVEY 
 
Survey for Caregivers of Individuals with Autism Spectrum Disorder 
 
CONSENT TO PARTICIPATE  
Thank you for your interest in the “Autism Spectrum Disorders Survey of Experiences, 
Interventions, and Resource Availability” research project.  
The experience of getting an ASD diagnosis and subsequently obtaining treatment 
services varies widely based on many factors, but it is not unusual for caregivers to report 
some difficulties obtaining services, or feel overwhelmed at times in the process of 
deciding which interventions to pursue.  
The purpose of this research is to learn more about the experiences of caregivers of 
individuals with Autism Spectrum Disorder (ASD). For this study, we want to hear 
from primary caregivers of individuals with ASD. We want to learn more about YOUR 
experience navigating the path to diagnosis and treatment for your child. We are 
collecting this data to inform efforts to improve this process, making it easier to get 
effective services for individuals with ASD.  
The procedure involves filling an online survey that will take approximately 15-20 
minutes. The survey questions will be about experiences related to assessment and 
interventions for Autism Spectrum Disorder.  
Your responses will be confidential and combined with the answers of other survey 
participants. To protect your privacy, we will not be collecting any information that could 
be traced to you individually, and the survey software (Qualtrics) allows us to block IP 
addresses from being collected. All data is stored in a password protected electronic 
format on a secure server. The results of this study will be used for scholarly purposes 
only and may be shared with Louisiana State University representatives.  
Your participation in this research study is voluntary. You may choose not to participate 
or withdraw from participation at any time during the survey by closing the window. 
Most questions will have a “prefer not to answer” or “not applicable” option. There is no 
incentive or payment for your participation, but we sincerely appreciate your contribution 
towards helping us understand how to improve services for individuals with ASD. If you 
wish to withdraw any information collected from the analysis, contact Lindsey Williams 
at lwil175@lsu.edu. 
This research project being conducted by graduate students in Clinical Psychology at 
Louisiana State University. If you have any questions about this research, you can contact 
Lindsey Williams at lwil175@lsu.edu .  
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This research has been reviewed and approved according to Louisiana State University 
Institutional Review Board procedures for research involving human subjects. Questions 
about subjects' rights or other concerns can be directed to Robert C. Mathews, Chairman, 
Institutional Review Board, (225) 578-8692, irb@lsu.edu, or via www.lsu.edu/irb.  
ELECTRONIC CONSENT: Please select your choice below. 
 
Clicking on the "agree" button below indicates that:  
 
• you have read the above information 
• you voluntarily agree to participate 
• you are at least 18 years of age  
 
If you do not wish to participate in the research study, please decline participation 
by clicking on the "disagree" button. 
 
Respondent Demographics 
o How did you learn about this survey? (Write in) 
 
o Your relationship to individual with ASD 
 Biological mother 
 Biological father 
 Adoptive mother 
 Adoptive father 
 Other (Write in)  
 
o Ethnicity 
 Caucasian 
 Latino  
 Middle Eastern 
 African American 
 Caribbean 
 South Asian 
 East Asian 
 Combination (Write in) 
 Other (Write in) 
 Prefer not to answer  
 
o Gender 
 Identify as male 
 Identify as female 
 Prefer not to answer  
 
o Highest level of education completed 
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 Some high school 
 High school graduate 
 Technical, associate, or professional degree 
 Some college 
 College graduate 
 Some graduate school 
 Graduate degree (e.g., Masters or above) 
 Prefer not to answer 
 
o Annual household income (US$) 
 Less than 10,000 
 10k-25k 
 25k-40k 
 40k-55k 
 55k-70k 
 70k-100k 
 More than 100k 
 Prefer not to answer 
 
o Current marital status 
 Single, never married 
 Married or in long-term relationship 
 Separated or Divorced 
 Widowed 
 Other 
 Prefer not to answer 
 
o Current state where you currently live (drop down) 
 
Designation of urban, suburban, and rural use the 2010 US Census criteria 
 
o How would you describe your city/town?  
 Urban (50,000+ people) 
 Suburban (2,500 to 49,000 people) 
 Rural (less than 2,500 people) 
 
Child/Adolescent Information 
o Age  (years, months)  
 
o Ethnicity 
 Caucasian 
 Latino  
 Middle Eastern 
 African American 
 Caribbean 
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 South Asian 
 East Asian 
 Combination (Write in) 
 Other (Write in) 
 Prefer not to answer  
 
o Gender 
 Identify as male 
 Identify as female 
 Prefer not to answer  
 
o Current Autism Spectrum Disorder diagnosis 
 Autistic Disorder 
 PDD-NOS (Pervasive Developmental Disorder, Not Otherwise 
Specified) 
 Asperger’s Disorder 
 Autism Spectrum Disorder  
 Not sure 
 Write in: _____ 
 
o How old was your child when he or she received the autism diagnosis you 
indicated above? (write in __ years and  __ months) 
 
Now you will see some questions related to different behaviors.  
 
1 Communication skills.  
2 Age appropriate self-help and adaptive skills (i.e., able to take care of self).  
3 Engages in repetitive motor movements for no reason (e.g., hand waving, 
body rocking, head banging, hand flapping).  
4 Verbal communication.  
5 Prefers foods of a certain texture or smell. 
6 Ability to recognize the emotions of others. 
7 Maintains eye contact.  
8 Social interactions with others his/her age.  
9 Response to others' social cues. 
10 Use of language in conversations with others.  
11 Shares enjoyment, interests, or achievement with others (e.g., parents, 
friends, caregivers).  
12 Ability to make and keep friends.  
13 Interest in participating in social games, sports, and activities. 
Rate each item for the extent that it is/was ever a problem. Compare the child 
to other children his/her age based on the following: 
0 = Not different; no impairment 
1 = Somewhat different; mild impairment 
2 = Very different; severe impairment 
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14 Interest in another person's side of the conversation (e.g., talks to people 
with intention of hearing what others have to say). 
15 Able to understand the subtle cues or gestures of others (e.g., sarcasm, 
crossing arms to show anger).  
16 Use of too few or too many social gestures.  
17 Body posture and/or gestures.  
18 Communicates effectively (e.g., using words, gestures or sign language).  
19 Displays a range of socially appropriate facial expressions.  
20 Restricted interests and activities.  
21 Eye-to-eye gaze.  
22 Reaction to sounds and sights.  
23 Walks or runs on toes/balls of feet (If unable to walk/run, rate "0"). 
24 Reads nonverbal cues (body language) of other people. (If blind, rate "0"). 
25 Expects others to know their thoughts, experiences, and opinions without 
communicating them (e.g. expects others to "read his/her mind"). 
26 Use of facial expressions.  
27 Saying words and phrases repetitively (If nonverbal, rate "0"). ____ 
28 Make-believe or pretend play. ____ 
29 Understanding of age appropriate jokes, figures of speech, or sayings. ____ 
30 Gives subtle cues or gestures when communicating with others (e.g., hinting).  
31 Becomes upset if there is a change in routine.  
32 Needs reassurance, especially if events don’t go as planned.  
33 Language development. 
34 Responds to others’ distress.  
35 Socializes with other children.  
36 Use of nonverbal communication.  
 
Diagnosis 
o Which, if any, difficulties did you experience when you were trying to get a 
diagnosis? Select all that apply. 
 Long wait list (longer than 1 month) for assessment 
 Transportation problems (too far to drive or we did not have easy 
access to transportation) 
 Scheduling problems (e.g., could not get time off of work, or could not 
arrange for necessary childcare for other children) 
 Insurance would not cover assessment 
 Insurance would cover part of assessment but out of pocket cost was 
still too high 
 Caregivers were unsure or disagreed with one another about whether 
to get assessment 
 Professionals reassured us that there was no problem or my child 
would “grow out of it” 
 Other (write in) 
 
o How old was your child when he or she began receiving any treatment for the 
autism diagnosis you indicated above? (Write in: ___ years and ___ months) 
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o Is your child currently taking prescribed medication meant to address 
symptoms related to autism, mood/anxiety, or Attention-
Deficit/Hyperactivity Disorder?  
 Yes, currently taking medication for autism symptoms (Write in) 
 Yes, currently taking medication for mood or anxiety symptoms 
(Write in) 
 Yes, currently taking medication for Attention-Deficit/Hyperactivity 
Disorder (Write in) 
 No, not currently taking medication for any of these reasons 
 
o Please indicate which, if any, of the following apply to your child: 
 Has received a diagnosis of Intellectual Disability (may be referred to 
as mental retardation in older reports) 
 Currently exhibits aggressive behavior toward other people (e.g., 
hitting, pinching, biting) 
 Currently exhibits self-injurious behavior (e.g., head banging, biting 
self, or other methods of injuring him or herself) 
 Sleep problems on a regular basis (more nights than not; e.g., takes 
more than 30 minutes to go to sleep, wakes up frequently during the 
night) 
 Has received a diagnosis of seizure disorder or epilepsy 
 
Insurance Information 
o What type of insurance coverage does your child have?  
 None 
 Private Insurance only (e.g., through a parent’s employer) 
 Medicaid or other public insurance 
 Both private insurance and Medicaid / public insurance 
 Not sure or prefer not to answer 
 
o If your child has insurance, does the insurance offer coverage for any autism 
treatment? 
 Yes, and I am satisfied with the coverage. They provide adequate 
coverage for both the types services and the amount of those services 
that my child needs. 
 Yes, for some things, but I have had difficulty getting them to cover 
services, or they don’t provide the types of services I want. 
 No 
 Not sure 
 
Autism Interventions 
o For the next few questions, we will be asking about types of treatments your 
child currently receives.  
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The lists below is presented in randomized order. The titles in italics 
will be the ones used by the researchers for the purposes of 
classification/analysis but will not be visible for the participants.  
 
Each list below will be prefaced with: Does your child currently use 
any of the following treatments? (yes/no) 
 
 List 1 EBP - EIBI 
 Early Intensive Behavioral Intervention  
 List 2 EBP - Behavioral 
 Applied Behavior Analysis (ABA)  
 Modeling 
 Pivotal Response Training 
 Natural Teaching Strategies 
 List 3 EBP – Cognitive Behavioral 
 Cognitive Behavioral Intervention Package  
 Cognitive Behavioral Therapy 
 List 4 EBP – Language  
 Language Training (Production) 
 Speech therapy 
 List 5 EBP – Non-clinician as Therapist 
 Parent Training 
 Peer Training Package 
 Self-Management Training 
 Schedules 
 List 6 EBP – Social Skills 
 Scripting 
 Social Skills Package 
 Story-Based Intervention (e.g., Social Stories) 
 List 7 CAM – Social/Communication 
 Alternative Communication Devices  
 Functional Communication Training 
 Picture Exchange Communication System 
 Sign Instruction 
 Facilitated Communication 
 Music Therapy 
 Animal-assisted Therapy 
 Floor Time 
 Play Therapy 
 List 8 CAM – Mind/Body 
 Exercise 
 Massage Therapy/Deep Pressure 
 Auditory and/or Sensory Integration 
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 Chiropractic 
 Art Therapy 
 Acupuncture 
 List 9 CAM – Biomedical 
 Vitamins and supplements 
 Special or restricted diets (e.g., gluten-free, casein-free, 
yeast-free) 
 Oxytocin 
 List 10 CAM – 2 
 Chelation 
 Hyperbaric oxygen therapy (HBOT) 
 Packing 
 List 11 CAM – Other 
 Occupational therapy 
 Physical therapy 
 Other (Write in) 
 
Once these questions are completed, the participant will continue to the next page, which 
will have an additional question related to each treatment group option endorsed as 
currently in use. 
o How many hours per week does your child spend receiving and/or using any 
of these treatments? (write in)  
 
Autism Intervention Information Sources 
o Where do you get information about autism treatments? (Select all that apply.) 
 Websites 
 Online forum/support group 
 Word of mouth from someone who is a caregiver of individual 
with ASD 
 Word of mouth from someone who is not a caregiver of individual 
with ASD  
 Doctor (pediatrician or primary care physician) 
 Magazines 
 Books 
 School/classroom teacher 
 ABA therapist 
 Occupational therapist 
 Physical therapist 
 Psychologist  
 Parent support group that meets in person 
 TV 
 Newspaper 
 Other (Write in) 
 
Once these questions are completed, the participant continues to the next question, which 
will only include the information sources endorsed in the previous question as options. 
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o Of the sources of information about autism treatments you use, which is your 
most trusted source? 
 
Intervention Barriers 
o Now you will again see some lists of interventions sometimes used for autism 
symptoms. Maybe your child currently uses some of these treatments; perhaps 
there are some he/she has never used. We would like to know if within each 
list of treatments you see any that your child used to use, but then quit using 
for some reason. There are 6 lists; some lists will be different than the lists 
you saw previously.  
 
Presentation of the following lists is randomized. Each list is preceded by the instruction 
below: 
o For the following list please select any treatments your child used to use but 
then quit. You can select as many as apply in each list. (If none of these apply, 
select “none of the above.”) 
 List 1 EBP – Past EBP List 1 
 Applied Behavior Analysis (ABA)  
 Cognitive Behavioral Intervention Package  
 Cognitive Behavioral Therapy  
 Modeling 
 Pivotal Response Training 
 None of the above 
 List 2 EBP—Past EIBI (listed separately due to high likelihood of 
“aged out of services” listed as reason no longer used) 
 Early Intensive Behavioral Intervention  
 None of the above 
 List 3 EBP – Past EBP List 3   
 Language Training (Production) 
 Natural Teaching Strategies 
 Parent Training 
 Peer Training Package 
 Schedules 
 Scripting 
 Self-Management Training 
 Social Skills Package 
 Speech therapy 
 Story-Based Intervention (e.g., Social Stories) 
 None of the above 
 List 4 non-EBP – Past 
 Alternative Communication Devices  
 Exercise 
 Functional Communication Training 
 Massage Therapy/Deep Pressure 
 Music Therapy 
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 Occupational Therapy 
 Physical Therapy 
 Picture Exchange Communication System 
 Sign Instruction 
 Structured Teaching 
 None of the above 
 List 5 CAM – Past  
 Acupuncture 
 Animal-assisted Therapy 
 Art Therapy 
 Auditory and/or Sensory Integration 
 Chiropractic/osteopathy 
 Facilitated Communication 
 Floor Time 
 Oxytocin  
 Play Therapy 
 Special or restricted diets (e.g., gluten-free, casein-free, 
yeast-free) 
 Vitamins and supplements 
 None of the above 
 List 6 non EBP – Dangerous 
 Chelation 
 Hyperbaric Oxygen Therapy (HBOT) 
 Packing / Holding Therapy 
 None of the above 
 List 7 
 Other (Write in) 
 None of the above 
 
For each list, if any answer other than “this question does not apply,” is selected, a 
drop-down box appears. 
o You said your child used to use but quit using the intervention(s) you selected 
above. Why? Think about the treatment(s) he/she quit using from this list. 
Below, select any of the reasons for quitting the intervention(s) you just listed.  
 
 Not seeing enough benefit from the treatment 
 Financial- out of pocket expense too great 
 My child was no longer eligible due to age or change in diagnosis 
 Change in insurance coverage  
 Took too much time or the scheduling was too inconvenient with 
other family obligations 
 Dissatisfied with the relationship with direct care providers (e.g., 
felt they were untrained, unprofessional, or inconsistent) 
 Did not like having service providers in my home 
 Proximity to my area- distance was too far to travel 
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 My child’s behavior interfered with treatment at that time (for 
example, aggression, self-injury, refusal to get out of car) 
 Other (write in) 
 
o Is there any treatment you wish your child were currently receiving? If you 
select “yes” you can list up to three. 
 No 
 Yes 
 (Write in) 
 (Write in) 
 (Write in) 
 
If “yes” is selected above, the next question appears, with a drop down box next to each 
option so the participant may select numbers 1-9 or “does not apply”:  
 
o Think about the treatments you wish your child could receive right now. 
Which of the following are the most frustrating/problematic right now? Select 
as many reasons as you think apply and rank them in order with 1 being the 
most frustrating/problematic. (If an option does not apply select “does not 
apply”)   
 Waitlists are too long 
 Distance- I have reliable transportation but the distance is just too 
far 
 Lack of Transportation- lack of reliable access to a vehicle and/or 
driver  
 Financial- out of pocket expense too great 
 Scheduling is too inconvenient for me / family (e.g., therapy time 
interferes with employment or other family obligations) 
 My child’s current treatments take so much time that I don’t want 
to add another at this time 
 I have tried or am trying to access this treatment, but the 
enrollment process is confusing/difficult  
 My child has challenging behaviors need to be addressed first (e.g., 
is aggressive, destructive, or runs away)  
 I just have not gotten around to it yet, no real barriers 
 Other (write in) 
  
END OF SURVEY 
 
Thank you for your participation in this study to help us understand more about services for 
Autism Spectrum Disorder (ASD). Below we have listed some additional information you may 
find to be useful.   
 
I’m looking for treatment for my child. What should I look for?  
ASD is a complex disorder that impacts each child differently; no single therapy works equally 
for every child. Some therapies are supported by research showing their efficacy, whereas others 
are not. The skill, experience, and style of the therapist are critical to the effectiveness of the 
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intervention. Before you choose an intervention, you will need to investigate the claims of each 
therapy so that you understand the possible risks and likely benefits for your child.  
 
As noted by the Autism Science Foundation, anyone can start a journal or post a study on the 
Internet to make scientific-sounding claims about dangerous or useless interventions. Fringe 
treatment providers prey on desperation and fear and deceive parents with numerous unfounded 
claims. These fringe treatments are often expensive and cumbersome, consuming time and money 
that could be more effectively used elsewhere. Remember there is no cure for ASD, but there are 
some treatments that have been reliably shown to help individuals with autism. We call these 
evidence-based treatments.  
 
The Autism Science Foundation sums this concept up nicely: “To be considered evidence-based, 
a treatment must be thoroughly investigated in multiple well-designed scientific studies and show 
measurable, sustained improvements in targeted areas. A study’s design largely depends on its 
focus and purpose, but there are some characteristics that well-designed studies tend to have.” See 
their list and brief explanations of these characteristics, along with an overview of some non-
evidence based practices, here:   
http://www.autismsciencefoundation.org/what-is-autism/autism-diagnosis/beware-non-evidence-
based-treatments 
 
Additionally, you should beware of any so-called interventions that can carry significant risk of 
physical harm—there are some purported interventions that are not only ineffective at treating 
ASD but have caused documented harm.  
 
What do you mean “dangerous practices?” 
Remember that there is no “cure” for ASD, and any treatment that claims to be one should be 
immediately questioned. Some of the “too good to be true” practices are medically invasive. Not 
only is there no indication that they treat ASD at all, but there have been documented cases of 
serious harm. These practices include: chelation therapy, bleach therapy, packing/holding 
therapy, and Miracle Mineral Solution. You can find some information on these practices on the 
Autism Science Foundation site: http://www.autismsciencefoundation.org/what-is-autism/autism-
diagnosis/beware-non-evidence-based-treatments 
Here are some tips from the Federal Drug Administration, which has been investigating false 
treatment claims: 
• Be suspicious of products that claim to treat a wide range of diseases.  
• Personal testimonials are no substitute for scientific evidence.  
• Few disorders can be treated quickly, so be suspicious of any therapy claimed as a 
“quick fix.”  
• “Miracle cures” which claim scientific breakthroughs and secret ingredients may be a 
hoax. 
(From here: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM394800.pdf ) 
 
How do I know what the best treatments for autism are?  
It is helpful to think about treatments based on the strength of scientific support that they reliably 
are helpful for most individuals they are designed to treat. The National Autism Center embarked 
on the National Standards Project to evaluate the evidence for different ASD treatments, 
specifically to make this information easy for families, caregivers, and practitioners to access 
quickly when making treatment choices. They use the following categories:  
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 Established Interventions: Have the most research support including multiple well-
conducted research studies. Examples: behavioral interventions, parent training, 
schedules, social skills packages 
 Emerging Interventions: Have some evidence but not as much evidence as Established 
Treatments. Before we can be assured these interventions are consistently effective, 
additional high quality studies are needed. Based on the available evidence, we are not 
able to rule out the possibility that these interventions are not effective. We need more 
research for a definitive answer. Examples: functional communication training, music 
therapy, picture exchange communication system, structured teaching 
 Unestablished Interventions: There is little to no scientific evidence to support the 
effectiveness of these interventions. There is no reason to assume these are effective; 
furthermore, there is no way to rule out the possibility they are ineffective or even 
harmful. Examples: animal assisted therapy, floor time, facilitated communication, 
sensory intervention package  
 
For the complete list and more information on the interventions identified by the National 
Standards Project in the above categories, please do the following:  
 Go to http://www.nationalautismcenter.org/national-standards-project/phase-2/ 
 Click on “download the free report.” 
 Follow the instructions to access a PDF.  
 The coverage of individual interventions begins on page 42. 
 
In summary:  
Remember that while every individual with ASD is unique, each has the potential to learn new 
skills to decrease problematic behavior, increase his/her independence, and enable him/her to 
engage in productive, enjoyable interactions with the environment and people in his/her life. 
Interventions targeting an individual’s specific needs can be very helpful in reaching these goals, 
but some interventions are more likely to be helpful than others. You should carefully consider 
the probable benefits and potential costs when deciding which treatments best fit the needs of 
your child and family.  
Contact Information:  
 If you would like to contact the researchers, you may email Lindsey Williams at 
lwil175@lsu.edu or Hilary Adams at hadams15@lsu.edu    Note: Up until this point, all 
information has been unidentifiable and anonymous; if you choose to email us, your 
email will in no way be linked to your participation data. 
 This research has been reviewed and approved according to Louisiana State University 
Institutional Review Board procedures for research involving human subjects. Questions 
about subjects' rights or other concerns can be directed to Robert C. Mathews, Chairman, 
Institutional Review Board, (225) 578-8692, irb@lsu.edu, or via www.lsu.edu/irb.  
Disclosure statement: The researchers have no ties with the National Autism Center, May 
Institute, or Autism Science Foundation. We simply provided the above links and related 
information because we think they contain useful information for making informed choices about 
ASD interventions. 
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APPENDIX B: LOUISIANA STATE UNIVERSITY IRB APPROVAL 
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APPENDIX C: NUMBER OF PARTICIPANTS BY RESEARCH QUESTION 
 
Various analyses had different numbers of participants due to reasons such as survey dropout and 
not yet having received treatment services. Additionally, the ASD-DC measure included in the 
study was developed for use with children ages 2-16; 20 participants fell outside of that age 
range and accordingly some analyses were run both with and without these participants when 
autism symptom severity was used as a dependent variable in the analysis. This guide is to 
outline how many participants were included in each set of analyses and for each individual 
analysis, as well as to outline reasons for exclusion at each stage. Research questions are 
italicized for easy reference. 
 
Participants in Initial Analyses 
 Started survey: 150 
 Retained for initial descriptive analyses: 88 
 
Participants in Analyses on Barriers to Diagnosis 
 Predictors of greatest number of diagnostic barriers:  
o 88 for inclusive analysis  
o 68 for analysis excluding those outside of ASD-DC age range 
 Predictors of professional reassurances as a perceived barrier: 88 
 Ethnic and familial barriers to diagnostic services: 88 
 
Analyses on Past Treatment 
 Of the initial 88, 4 participants were removed at this stage because they have not begun 
receiving treatment.  
 Time from diagnosis to treatment 
o 84 participants for inclusive analysis 
o 63 for analysis excluding those outside ASD-DC age range 
 For future questions on treatment, 6 more were removed because they dropped out of 
survey before answering questions on past treatments, leaving 78 participants for 
remaining questions on treatment services. 
 Factors predicting barriers to EBPs:  
o 78 for inclusive analysis 
o 60 excluding those outside of age range for ASD-DC 
 Predictors of time between ASD diagnosis and first ASD symptom treatment: 
o 84 for inclusive analysis (4 excluded because had not begun receiving treatment 
yet) 
o 63 excluding those outside of ASD-DC range 
 
Analyses on Currently Desired Interventions 
 51 total participants indicated they were interested in future services; of these, 41 of the 
answers could be clearly categorized into EBP or non-EBP. 
 Descriptive analysis: 51 
 Predictors of desiring EBP over non-EBP: 41 
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